
Fig 1.
Detection of differentially expressed miRNAs in PC-3 cells treated with SAM and controls. (A) Heatmap of differentially expressed miRNAs in PC-3 cells treated with SAM and untreated controls. Seventeen differentially expressed mature miRNAs (7 upregulated and 10 downregulated) were detected (P < 0.005). Clustering clearly distinguished between the treated samples and controls as well as between the upregulated and downregulated groups. (B) A volcano plot displaying the differentially expressed miRNAs. miRNAs, microRNA; SAM, S-adenosylmethionine.

Fig 2.
Combined analyses of miRNA expression and RNA-seq data. The differentially expressed genes of the transcriptome that were matched to target genes were detected via three different miRNA databases (miRDB, TargetScan, and miRanda). (A) A total of 92 downregulated genes were associated with upregulated miRNAs, and (B) 41 upregulated genes were associated with downregulated miRNAs. The genes are shown in the boxes. (C) Gene expression levels of StarD13 following treatment with 200 μm SAM. A significant increase in the expression of StarD13 was observed (211% of the control). miRNA, microRNA; SAM, S-adenosylmethionine; StarD13, StAR-related lipid transfer domain containing 13.

Fig 3.
(A) Differential expression of hsa-miR-192-5p (after 24, 48, and 120 h) in untreated PC-3 cells or mock-transfected PC-3 cells. Since both groups displayed almost no differences, we described them as controls and set them to 100%. The expression of hsa-miR-192-5p was significantly downregulated following treatment with SAM (60% of the control after 48 h and 45% after 120 h), after transfection with the miRNA agomir (70% of the control after 24 h, 29% of the control after 48 h, and 19% after 120 h), or after combination treatment (68% of the control after 24 h, 13% of the control after 48 h, and 9% of the control after 120 h). (B) Transfection with the hsa-miR-192-5p agomir alone or in combination with SAM inhibited the proliferation of PC-3 cells. Twenty-four hours after PC-3 cells were transfected with the hsa-miR-192-5p agomir, and the cells were seeded in 96-well plates and grown for 24 h, 48 h, or 120 h. Proliferation was measured using the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide assay. Differences between untransfected PC-3 cells (PC-3) and mock-transfected PC-3 cells (miR-NC) were hardly detectable. Transfection with the hsa-miR-192-5p agomir resulted in significantly diminished proliferation of 71% (after 48 h) and 62% (after 120 h) compared to that of the controls. A combination of SAM treatment and transfection with the miRNA agomir decreased the proliferation rate of PC-3 cells even more clearly (70% of the control after 24 h, 40% of the control after 48 h, and 23% of the control after 120 h). (C) A fluorogenic caspase activity assay revealed a significant upregulation of the caspase-3 activity in PC-3 cells after transfection with hsa-miR-192-5p agomir or a combination of SAM treatment and hsa-miR-192-5p agomir transfection for 120 h. The results are expressed as the means ± SDs of three independent experiments: *P < 0.01, **P < 0.001, ***P < 0.0001, and ****P < 0.00001. miRNA, microRNA; SAM, S-adenosylmethionine.

Fig 4.
GO term enrichment and KEGG pathway analysis of differentially methylated regions. Differentially expressed transcripts identified in (A) downregulated expression genes and in (B) upregulated expression genes. GO enrichment was used to identify enriched regulatory motifs, molecular functions, BP, and CC, as was KEGG pathway enrichment (C). BP, biological process; CC, cellular component; GO, gene ontology.
Table S1.
Functional enrichment analysis (BP) of the downregulated genes
| ID | Description | GeneRatio | BgRatio | p value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0048485 | Sympathetic nervous system development | 4/86 | 21/18866 | 2.27016E-06 | 0.002377266 | 0.001927173 | GATA3/SOX4/SEMA3A/TP63 | 4 |
| GO:0003283 | Atrial septum development | 4/86 | 23/18866 | 3.3355E-06 | 0.002377266 | 0.001927173 | TGFB2/SOX4/ANK2/BMPR2 | 4 |
| GO:0003179 | Heart valve morphogenesis | 5/86 | 52/18866 | 3.8427E-06 | 0.002377266 | 0.001927173 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003181 | Atrioventricular valve morphogenesis | 4/86 | 24/18866 | 3.9887E-06 | 0.002377266 | 0.001927173 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0003171 | Atrioventricular valve development | 4/86 | 26/18866 | 5.57292E-06 | 0.002481207 | 0.002011434 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0031069 | Hair follicle morphogenesis | 4/86 | 28/18866 | 7.57961E-06 | 0.002481207 | 0.002011434 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0003170 | Heart valve development | 5/86 | 61/18866 | 8.51768E-06 | 0.002481207 | 0.002011434 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003183 | Mitral valve morphogenesis | 3/86 | 10/18866 | 1.07242E-05 | 0.002481207 | 0.002011434 | SMAD6/SOX4/BMPR2 | 3 |
| GO:0071772 | Response to BMP | 7/86 | 168/18866 | 1.16587E-05 | 0.002481207 | 0.002011434 | SORL1/FST/GATA3/SKIL/SMAD6/TGFB2/BMPR2 | 7 |
| GO:0071773 | Cellular response to BMP stimulus | 7/86 | 168/18866 | 1.16587E-05 | 0.002481207 | 0.002011434 | SORL1/FST/GATA3/SKIL/SMAD6/TGFB2/BMPR2 | 7 |
| GO:0048880 | Sensory system development | 10/86 | 394/18866 | 1.2143E-05 | 0.002481207 | 0.002011434 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SEMA3A/SLITRK6/BMPR2 | 10 |
| GO:0048730 | Epidermis morphogenesis | 4/86 | 32/18866 | 1.31282E-05 | 0.002481207 | 0.002011434 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0003279 | Cardiac septum development | 6/86 | 114/18866 | 1.35301E-05 | 0.002481207 | 0.002011434 | GATA3/SMAD6/TGFB2/SOX4/ANK2/BMPR2 | 6 |
| GO:0003174 | Mitral valve development | 3/86 | 11/18866 | 1.46971E-05 | 0.002502712 | 0.002028868 | SMAD6/SOX4/BMPR2 | 3 |
| GO:0003230 | Cardiac atrium development | 4/86 | 36/18866 | 2.12083E-05 | 0.003370699 | 0.002732516 | TGFB2/SOX4/ANK2/BMPR2 | 4 |
| GO:1905314 | Semi-lunar valve development | 4/86 | 37/18866 | 2.36965E-05 | 0.003515909 | 0.002850233 | GATA3/SMAD6/TGFB2/BMPR2 | 4 |
| GO:0003281 | Ventricular septum development | 5/86 | 76/18866 | 2.50715E-05 | 0.003515909 | 0.002850233 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0060413 | Atrial septum morphogenesis | 3/86 | 16/18866 | 4.9065E-05 | 0.006498385 | 0.00526803 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0048483 | Autonomic nervous system development | 4/86 | 47/18866 | 6.18134E-05 | 0.007400207 | 0.005999108 | GATA3/SOX4/SEMA3A/TP63 | 4 |
| GO:0001654 | Eye development | 9/86 | 384/18866 | 6.30723E-05 | 0.007400207 | 0.005999108 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SLITRK6/BMPR2 | 9 |
| GO:0030510 | Regulation of BMP signaling pathway | 5/86 | 93/18866 | 6.63775E-05 | 0.007400207 | 0.005999108 | SORL1/FST/SKIL/SMAD6/BMPR2 | 5 |
| GO:0150063 | Visual system development | 9/86 | 388/18866 | 6.82905E-05 | 0.007400207 | 0.005999108 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/BDNF/SLITRK6/BMPR2 | 9 |
| GO:0030509 | BMP signaling pathway | 6/86 | 155/18866 | 7.63551E-05 | 0.007914368 | 0.006415922 | SORL1/FST/SKIL/SMAD6/TGFB2/BMPR2 | 6 |
| GO:0003215 | Cardiac right ventricle morphogenesis | 3/86 | 20/18866 | 9.85737E-05 | 0.009791656 | 0.007937778 | GATA3/TGFB2/SOX4 | 3 |
| GO:0003177 | Pulmonary valve development | 3/86 | 21/18866 | 0.000114624 | 0.010930574 | 0.008861062 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0016358 | Dendrite development | 7/86 | 247/18866 | 0.000135064 | 0.012023407 | 0.009746987 | CPEB3/PPP1R9A/BDNF/SEMA3A/PRKG1/PACSIN1/MAP2 | 7 |
| GO:0043010 | Camera-type eye development | 8/86 | 332/18866 | 0.000136171 | 0.012023407 | 0.009746987 | SLC7A11/COL8A1/GATA3/CLIC4/SKIL/TGFB2/SLITRK6/BMPR2 | 8 |
| GO:0003205 | Cardiac chamber development | 6/86 | 174/18866 | 0.000144194 | 0.012277131 | 0.009952673 | GATA3/SMAD6/TGFB2/SOX4/ANK2/BMPR2 | 6 |
| GO:0010634 | Positive regulation of epithelial cell migration | 6/86 | 176/18866 | 0.000153468 | 0.01261616 | 0.010227512 | GATA3/SASH1/TGFB2/HDAC9/BMPR2/ITGB3 | 6 |
| GO:0090092 | Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7/86 | 254/18866 | 0.000160478 | 0.012752643 | 0.010338155 | SORL1/FST/SKIL/SMAD6/TGFB2/INHBB/BMPR2 | 7 |
| GO:0060393 | Regulation of pathway-restricted SMAD protein phosphorylation | 4/86 | 62/18866 | 0.000183531 | 0.014114136 | 0.011441873 | SMAD6/TGFB2/INHBB/BMPR2 | 4 |
| GO:0060037 | Pharyngeal system development | 3/86 | 26/18866 | 0.000220418 | 0.015457062 | 0.012530539 | GATA3/TGFB2/BMPR2 | 3 |
| GO:0060384 | Innervation | 3/86 | 26/18866 | 0.000220418 | 0.015457062 | 0.012530539 | GABRB3/SEMA3A/SLITRK6 | 3 |
| GO:0060389 | Pathway-restricted SMAD protein phosphorylation | 4/86 | 65/18866 | 0.000220445 | 0.015457062 | 0.012530539 | SMAD6/TGFB2/INHBB/BMPR2 | 4 |
| GO:0003148 | Outflow tract septum morphogenesis | 3/86 | 27/18866 | 0.000247155 | 0.016834784 | 0.013647414 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0031032 | Actomyosin structure organization | 6/86 | 200/18866 | 0.000306151 | 0.020274023 | 0.016435493 | PPP1R9A/NEBL/CGNL1/PGM5/ARHGAP28/MYO18A | 6 |
| GO:0003206 | Cardiac chamber morphogenesis | 5/86 | 131/18866 | 0.000331986 | 0.020492366 | 0.016612497 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003231 | Cardiac ventricle development | 5/86 | 131/18866 | 0.000331986 | 0.020492366 | 0.016612497 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0003209 | Cardiac atrium morphogenesis | 3/86 | 30/18866 | 0.00033969 | 0.020492366 | 0.016612497 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0010595 | Positive regulation of endothelial cell migration | 5/86 | 132/18866 | 0.000343832 | 0.020492366 | 0.016612497 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0032535 | Regulation of cellular component size | 8/86 | 383/18866 | 0.000358164 | 0.020825902 | 0.016882884 | PPP1R9A/BDNF/SEMA3A/ATP7A/ARHGAP28/BMPR2/JMY/MAP2 | 8 |
| GO:0051497 | Negative regulation of stress fiber assembly | 3/86 | 31/18866 | 0.00037485 | 0.021277191 | 0.017248729 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0003176 | Aortic valve development | 3/86 | 32/18866 | 0.000412269 | 0.022856978 | 0.018529411 | GATA3/SMAD6/BMPR2 | 3 |
| GO:0060411 | Cardiac septum morphogenesis | 4/86 | 77/18866 | 0.00042271 | 0.022903202 | 0.018566884 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0010632 | Regulation of epithelial cell migration | 7/86 | 301/18866 | 0.000449424 | 0.023809483 | 0.019301576 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0021675 | Nerve development | 4/86 | 79/18866 | 0.000466089 | 0.024155573 | 0.01958214 | GABRB3/BDNF/SEMA3A/SLITRK6 | 4 |
| GO:0032232 | Negative regulation of actin filament bundle assembly | 3/86 | 34/18866 | 0.000494123 | 0.025063604 | 0.020318252 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0010769 | Regulation of cell morphogenesis involved in differentiation | 7/86 | 310/18866 | 0.000535603 | 0.025683957 | 0.020821152 | PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/MAP2/NEDD9 | 7 |
| GO:0090287 | Regulation of cellular response to growth factor stimulus | 7/86 | 310/18866 | 0.000535603 | 0.025683957 | 0.020821152 | SORL1/FST/GATA3/SKIL/SMAD6/BMPR2/ITGB3 | 7 |
| GO:0110111 | Negative regulation of animal organ morphogenesis | 3/86 | 35/18866 | 0.000538674 | 0.025683957 | 0.020821152 | GATA3/TGFB2/BMPR2 | 3 |
| GO:0002088 | Lens development in camera-type eye | 4/86 | 83/18866 | 0.000562221 | 0.026281074 | 0.021305215 | SLC7A11/GATA3/SKIL/SLITRK6 | 4 |
| GO:0000289 | Nuclear-transcribed mRNA poly(A) tail shortening | 3/86 | 36/18866 | 0.000585716 | 0.026852821 | 0.021768712 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0016331 | Morphogenesis of embryonic epithelium | 5/86 | 151/18866 | 0.000635718 | 0.028595307 | 0.023181289 | GATA3/TGFB2/SOX4/MTHFR/TP63 | 5 |
| GO:0001942 | Hair follicle development | 4/86 | 87/18866 | 0.00067167 | 0.029652983 | 0.024038713 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0007050 | Cell cycle arrest | 6/86 | 234/18866 | 0.000702266 | 0.030276819 | 0.024544437 | SKIL/TGFB2/SOX4/JMY/TP53INP1/CNOT6L | 6 |
| GO:0022404 | Molting cycle process | 4/86 | 89/18866 | 0.000731697 | 0.030276819 | 0.024544437 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0022405 | Hair cycle process | 4/86 | 89/18866 | 0.000731697 | 0.030276819 | 0.024544437 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:1902904 | Negative regulation of supramolecular fiber organization | 5/86 | 156/18866 | 0.0007366 | 0.030276819 | 0.024544437 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0098773 | Skin epidermis development | 4/86 | 90/18866 | 0.000763091 | 0.030834037 | 0.024996155 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:1902895 | Positive regulation of pri-miRNA transcription by RNA polymerase II | 3/86 | 40/18866 | 0.000799907 | 0.031782969 | 0.025765423 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0048286 | Lung alveolus development | 3/86 | 41/18866 | 0.000860228 | 0.03260155 | 0.026429021 | SLC7A11/ATP7A/BMPR2 | 3 |
| GO:0014909 | Smooth muscle cell migration | 4/86 | 93/18866 | 0.000862978 | 0.03260155 | 0.026429021 | SORL1/ATP7A/PRKG1/ITGB3 | 4 |
| GO:0009267 | Cellular response to starvation | 5/86 | 163/18866 | 0.000897377 | 0.03260155 | 0.026429021 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0051494 | Negative regulation of cytoskeleton organization | 5/86 | 163/18866 | 0.000897377 | 0.03260155 | 0.026429021 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0045713 | Low-density lipoprotein particle receptor biosynthetic process | 2/86 | 10/18866 | 0.00090256 | 0.03260155 | 0.026429021 | ITGAV/ITGB3 | 2 |
| GO:1904526 | Regulation of microtubule binding | 2/86 | 10/18866 | 0.00090256 | 0.03260155 | 0.026429021 | TTBK2/MAP2 | 2 |
| GO:0051100 | Negative regulation of binding | 5/86 | 169/18866 | 0.001054847 | 0.037420693 | 0.030335744 | SORL1/RSF1/TTBK2/ARHGAP28/MAP2 | 5 |
| GO:0050673 | Epithelial cell proliferation | 8/86 | 453/18866 | 0.001072913 | 0.037420693 | 0.030335744 | FST/COL8A1/GATA3/TGFB2/ATP7A/BMPR2/ITGB3/TP63 | 8 |
| GO:0098917 | Retrograde transsynaptic signaling | 2/86 | 11/18866 | 0.001099862 | 0.037420693 | 0.030335744 | BDNF/PLCB1 | 2 |
| GO:0032924 | Activin receptor signaling pathway | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | FST/INHBB/BMPR2 | 3 |
| GO:0046189 | Phenol-containing compound biosynthetic process | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | SLC7A11/GATA3/TGFB2 | 3 |
| GO:0060412 | Ventricular septum morphogenesis | 3/86 | 45/18866 | 0.001130155 | 0.037420693 | 0.030335744 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0060840 | Artery development | 4/86 | 102/18866 | 0.001217645 | 0.038883859 | 0.031521885 | SMAD6/TGFB2/SOX4/BMPR2 | 4 |
| GO:0007178 | Transmembrane receptor protein serine/threonine kinase signaling pathway | 7/86 | 359/18866 | 0.001263006 | 0.038883859 | 0.031521885 | SORL1/FST/SKIL/SMAD6/TGFB2/INHBB/BMPR2 | 7 |
| GO:0050919 | Negative chemotaxis | 3/86 | 47/18866 | 0.001282991 | 0.038883859 | 0.031521885 | SEMA3A/ITGAV/ITGB3 | 3 |
| GO:0070997 | Neuron death | 7/86 | 360/18866 | 0.001283364 | 0.038883859 | 0.031521885 | SORL1/SLC7A11/GATA3/GABRB3/TGFB2/BDNF/TP63 | 7 |
| GO:0051798 | Positive regulation of hair follicle development | 2/86 | 12/18866 | 0.001315929 | 0.038883859 | 0.031521885 | FST/TGFB2 | 2 |
| GO:0060213 | Positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/86 | 12/18866 | 0.001315929 | 0.038883859 | 0.031521885 | CPEB3/TNRC6C | 2 |
| GO:0010862 | Positive regulation of pathway-restricted SMAD protein phosphorylation | 3/86 | 48/18866 | 0.001364044 | 0.038883859 | 0.031521885 | TGFB2/INHBB/BMPR2 | 3 |
| GO:0072331 | Signal transduction by p53 class mediator | 6/86 | 267/18866 | 0.001386923 | 0.038883859 | 0.031521885 | NUAK1/SOX4/JMY/TP53INP1/TP63/CNOT6L | 6 |
| GO:0010631 | Epithelial cell migration | 7/86 | 365/18866 | 0.001389051 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0014812 | Muscle cell migration | 4/86 | 106/18866 | 0.001403922 | 0.038883859 | 0.031521885 | SORL1/ATP7A/PRKG1/ITGB3 | 4 |
| GO:0008361 | Regulation of cell size | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | BDNF/SEMA3A/ATP7A/BMPR2/MAP2 | 5 |
| GO:0048736 | Appendage development | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | SLC7A11/TGFB2/SOX4/BMPR2/TP63 | 5 |
| GO:0060173 | Limb development | 5/86 | 181/18866 | 0.001430229 | 0.038883859 | 0.031521885 | SLC7A11/TGFB2/SOX4/BMPR2/TP63 | 5 |
| GO:0051098 | Regulation of binding | 7/86 | 367/18866 | 0.001433187 | 0.038883859 | 0.031521885 | SORL1/GATA3/RSF1/BDNF/TTBK2/ARHGAP28/MAP2 | 7 |
| GO:0090132 | Epithelium migration | 7/86 | 368/18866 | 0.001455662 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0061014 | Positive regulation of mRNA catabolic process | 3/86 | 50/18866 | 0.001535648 | 0.038883859 | 0.031521885 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0010745 | Negative regulation of macrophage derived foam cell differentiation | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | ITGAV/ITGB3 | 2 |
| GO:0042415 | Norepinephrine metabolic process | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | GATA3/ATP7A | 2 |
| GO:0042635 | Positive regulation of hair cycle | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | FST/TGFB2 | 2 |
| GO:1903651 | Positive regulation of cytoplasmic transport | 2/86 | 13/18866 | 0.001550587 | 0.038883859 | 0.031521885 | SORL1/MAP2 | 2 |
| GO:0018958 | Phenol-containing compound metabolic process | 4/86 | 109/18866 | 0.001556068 | 0.038883859 | 0.031521885 | SLC7A11/GATA3/TGFB2/ATP7A | 4 |
| GO:0007409 | Axonogenesis | 8/86 | 482/18866 | 0.001590594 | 0.038883859 | 0.031521885 | GATA3/SKIL/ETV1/BDNF/SEMA3A/SLITRK6/BMPR2/MAP2 | 8 |
| GO:0090130 | Tissue migration | 7/86 | 374/18866 | 0.00159637 | 0.038883859 | 0.031521885 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0051051 | Negative regulation of transport | 8/86 | 483/18866 | 0.001611458 | 0.038883859 | 0.031521885 | PPP1R9A/SESTD1/ATP7A/HDAC9/ITGAV/INHBB/PACSIN1/ITGB3 | 8 |
| GO:0050770 | Regulation of axonogenesis | 5/86 | 186/18866 | 0.001612647 | 0.038883859 | 0.031521885 | SKIL/BDNF/SEMA3A/BMPR2/MAP2 | 5 |
| GO:0090102 | Cochlea development | 3/86 | 51/18866 | 0.001626288 | 0.038883859 | 0.031521885 | GATA3/GABRB3/SLITRK6 | 3 |
| GO:1902893 | Regulation of pri-miRNA transcription by RNA polymerase II | 3/86 | 51/18866 | 0.001626288 | 0.038883859 | 0.031521885 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0042303 | Molting cycle | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0042633 | Hair cycle | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | FST/TGFB2/ATP7A/TP63 | 4 |
| GO:0061387 | Regulation of extent of cell growth | 4/86 | 111/18866 | 0.001663655 | 0.038883859 | 0.031521885 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0030514 | Negative regulation of BMP signaling pathway | 3/86 | 52/18866 | 0.001720211 | 0.039815365 | 0.032277027 | SORL1/SKIL/SMAD6 | 3 |
| GO:0007548 | Sex differentiation | 6/86 | 280/18866 | 0.001764948 | 0.040458044 | 0.032798026 | FST/GATA3/TGFB2/SEMA3A/INHBB/TP63 | 6 |
| GO:0060211 | Regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2/86 | 14/18866 | 0.001803668 | 0.040875705 | 0.03313661 | CPEB3/TNRC6C | 2 |
| GO:0061614 | Pri-miRNA transcription by RNA polymerase II | 3/86 | 53/18866 | 0.00181746 | 0.040875705 | 0.03313661 | GATA3/SMAD6/TGFB2 | 3 |
| GO:0006584 | Catecholamine metabolic process | 3/86 | 54/18866 | 0.001918077 | 0.042339775 | 0.034323484 | GATA3/TGFB2/ATP7A | 3 |
| GO:0009712 | Catechol-containing compound metabolic process | 3/86 | 54/18866 | 0.001918077 | 0.042339775 | 0.034323484 | GATA3/TGFB2/ATP7A | 3 |
| GO:0030900 | Forebrain development | 7/86 | 391/18866 | 0.002053275 | 0.044167892 | 0.03580548 | SLC7A11/BCAN/SEMA3A/ATP7A/SLC38A2/PLCB1/PRKG1 | 7 |
| GO:0048839 | Inner ear development | 5/86 | 197/18866 | 0.002073551 | 0.044167892 | 0.03580548 | GATA3/GABRB3/TGFB2/BDNF/SLITRK6 | 5 |
| GO:0007638 | Mechanosensory behavior | 2/86 | 15/18866 | 0.002075002 | 0.044167892 | 0.03580548 | ETV1/SLITRK6 | 2 |
| GO:0050746 | Regulation of lipoprotein metabolic process | 2/86 | 15/18866 | 0.002075002 | 0.044167892 | 0.03580548 | ITGAV/ITGB3 | 2 |
| GO:0010976 | Positive regulation of neuron projection development | 6/86 | 290/18866 | 0.002105428 | 0.044418936 | 0.036008992 | CPEB3/PPP1R9A/SKIL/BDNF/BMPR2/PACSIN1 | 6 |
| GO:0031346 | Positive regulation of cell projection organization | 7/86 | 394/18866 | 0.002143474 | 0.044824937 | 0.036338124 | CPEB3/PPP1R9A/SKIL/BDNF/ATP7A/BMPR2/PACSIN1 | 7 |
| GO:0007613 | Memory | 4/86 | 121/18866 | 0.002280062 | 0.047266679 | 0.038317566 | CPEB3/ATXN1/BDNF/PLCB1 | 4 |
| GO:0042035 | Regulation of cytokine biosynthetic process | 2/86 | 16/18866 | 0.002364421 | 0.048592932 | 0.039392716 | GATA3/INHBB | 2 |
| GO:0048675 | Axon extension | 4/86 | 123/18866 | 0.00241989 | 0.049307834 | 0.039972264 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0042594 | Response to starvation | 5/86 | 206/18866 | 0.002516912 | 0.050850145 | 0.041222566 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0001838 | Embryonic epithelial tube formation | 4/86 | 125/18866 | 0.002565513 | 0.051396495 | 0.041665474 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0035904 | Aorta development | 3/86 | 60/18866 | 0.002594751 | 0.051549046 | 0.041789142 | SMAD6/TGFB2/SOX4 | 3 |
| GO:0003184 | Pulmonary valve morphogenesis | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | SMAD6/TGFB2 | 2 |
| GO:0006750 | Glutathione biosynthetic process | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | SLC7A11/CHAC1 | 2 |
| GO:1900363 | Regulation of mRNA polyadenylation | 2/86 | 17/18866 | 0.00267176 | 0.051784349 | 0.041979895 | CPEB3/CCNT1 | 2 |
| GO:0001704 | Formation of primary germ layer | 4/86 | 127/18866 | 0.002717051 | 0.052237505 | 0.042347253 | COL8A1/ITGAV/BMPR2/ITGB3 | 4 |
| GO:0070527 | Platelet aggregation | 3/86 | 62/18866 | 0.002849026 | 0.054336625 | 0.044048942 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0060080 | Inhibitory postsynaptic potential | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | GABRB3/BDNF | 2 |
| GO:0061298 | Retina vasculature development in camera-type eye | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | CLIC4/BMPR2 | 2 |
| GO:1900153 | Positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/86 | 18/18866 | 0.002996851 | 0.055816359 | 0.045248514 | CPEB3/TNRC6C | 2 |
| GO:0072175 | Epithelial tube formation | 4/86 | 133/18866 | 0.003208333 | 0.058835885 | 0.047696346 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0090101 | Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4/86 | 133/18866 | 0.003208333 | 0.058835885 | 0.047696346 | SORL1/FST/SKIL/SMAD6 | 4 |
| GO:0019184 | Nonribosomal peptide biosynthetic process | 2/86 | 19/18866 | 0.003339532 | 0.060550663 | 0.049086461 | SLC7A11/CHAC1 | 2 |
| GO:0045785 | Positive regulation of cell adhesion | 7/86 | 428/18866 | 0.003395248 | 0.060550663 | 0.049086461 | MAGI1/COL8A1/GATA3/TGFB2/SOX4/ITGAV/NEDD9 | 7 |
| GO:0042490 | Mechanoreceptor differentiation | 3/86 | 66/18866 | 0.00340238 | 0.060550663 | 0.049086461 | GABRB3/BDNF/SLITRK6 | 3 |
| GO:0031669 | Cellular response to nutrient levels | 5/86 | 221/18866 | 0.003403435 | 0.060550663 | 0.049086461 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:1901214 | Regulation of neuron death | 6/86 | 321/18866 | 0.003481234 | 0.061476012 | 0.049836611 | SORL1/SLC7A11/GATA3/GABRB3/TGFB2/BDNF | 6 |
| GO:0008406 | Gonad development | 5/86 | 223/18866 | 0.00353664 | 0.06199522 | 0.050257517 | FST/GATA3/TGFB2/SEMA3A/INHBB | 5 |
| GO:0043583 | Ear development | 5/86 | 224/18866 | 0.003604631 | 0.062552759 | 0.050709496 | GATA3/GABRB3/TGFB2/BDNF/SLITRK6 | 5 |
| GO:0007015 | Actin filament organization | 7/86 | 434/18866 | 0.003664496 | 0.062552759 | 0.050709496 | PPP1R9A/NEBL/CGNL1/ARHGAP28/PACSIN1/JMY/NEDD9 | 7 |
| GO:0002320 | Lymphoid progenitor cell differentiation | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | GATA3/SOX4 | 2 |
| GO:0042089 | Cytokine biosynthetic process | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | GATA3/INHBB | 2 |
| GO:1900151 | Regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2/86 | 20/18866 | 0.003699639 | 0.062552759 | 0.050709496 | CPEB3/TNRC6C | 2 |
| GO:0045137 | Development of primary sexual characteristics | 5/86 | 229/18866 | 0.003958763 | 0.065577145 | 0.053161267 | FST/GATA3/TGFB2/SEMA3A/INHBB | 5 |
| GO:0001655 | Urogenital system development | 6/86 | 330/18866 | 0.003983793 | 0.065577145 | 0.053161267 | GATA3/SMAD6/TGFB2/SOX4/BDNF/TP63 | 6 |
| GO:0009713 | Catechol-containing compound biosynthetic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0042107 | Cytokine metabolic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/INHBB | 2 |
| GO:0042423 | Catecholamine biosynthetic process | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0051797 | Regulation of hair follicle development | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | FST/TGFB2 | 2 |
| GO:0060065 | Uterus development | 2/86 | 21/18866 | 0.004077009 | 0.065577145 | 0.053161267 | GATA3/TGFB2 | 2 |
| GO:0048608 | Reproductive structure development | 7/86 | 443/18866 | 0.004098572 | 0.065577145 | 0.053161267 | FST/GATA3/TGFB2/SEMA3A/INHBB/BMPR2/TP63 | 7 |
| GO:0015800 | Acidic amino acid transport | 3/86 | 71/18866 | 0.004180801 | 0.066006816 | 0.053509587 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0033627 | Cell adhesion mediated by integrin | 3/86 | 71/18866 | 0.004180801 | 0.066006816 | 0.053509587 | TGFB2/ITGAV/ITGB3 | 3 |
| GO:0061458 | Reproductive system development | 7/86 | 447/18866 | 0.004303588 | 0.06749838 | 0.05471875 | FST/GATA3/TGFB2/SEMA3A/INHBB/BMPR2/TP63 | 7 |
| GO:0070988 | Demethylation | 3/86 | 72/18866 | 0.004348359 | 0.067754826 | 0.054926642 | GATA3/TET2/JMJD1C | 3 |
| GO:0043254 | Regulation of protein-containing complex assembly | 7/86 | 449/18866 | 0.004408972 | 0.068253172 | 0.055330636 | SORL1/PPP1R9A/SMAD6/ARHGAP28/ATF7IP/JMY/MAP2 | 7 |
| GO:0010888 | Negative regulation of lipid storage | 2/86 | 22/18866 | 0.004471481 | 0.068774263 | 0.055753068 | ITGAV/ITGB3 | 2 |
| GO:0003208 | Cardiac ventricle morphogenesis | 3/86 | 73/18866 | 0.004519944 | 0.069074013 | 0.055996065 | GATA3/TGFB2/SOX4 | 3 |
| GO:0051047 | Positive regulation of secretion | 6/86 | 340/18866 | 0.00460332 | 0.069900087 | 0.056665737 | SORL1/SYTL2/TGFB2/SOX4/MYO18A/INHBB | 6 |
| GO:0010594 | Regulation of endothelial cell migration | 5/86 | 238/18866 | 0.004657999 | 0.070185555 | 0.056897156 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0050804 | Modulation of chemical synaptic transmission | 7/86 | 454/18866 | 0.004681 | 0.070185555 | 0.056897156 | CPEB3/PPP1R9A/FBXL20/SLC7A11/SLC24A1/BDNF/PLCB1 | 7 |
| GO:0099177 | Regulation of trans-synaptic signaling | 7/86 | 455/18866 | 0.004736897 | 0.070579766 | 0.05721673 | CPEB3/PPP1R9A/FBXL20/SLC7A11/SLC24A1/BDNF/PLCB1 | 7 |
| GO:0048844 | Artery morphogenesis | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | TGFB2/SOX4/BMPR2 | 3 |
| GO:0050805 | Negative regulation of synaptic transmission | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | PPP1R9A/SLC24A1/BDNF | 3 |
| GO:1900006 | Positive regulation of dendrite development | 3/86 | 75/18866 | 0.004875303 | 0.070980628 | 0.057541696 | CPEB3/PPP1R9A/PACSIN1 | 3 |
| GO:0032799 | Low-density lipoprotein receptor particle metabolic process | 2/86 | 23/18866 | 0.004882896 | 0.070980628 | 0.057541696 | ITGAV/ITGB3 | 2 |
| GO:0035148 | Tube formation | 4/86 | 150/18866 | 0.004922269 | 0.071119327 | 0.057654135 | GATA3/TGFB2/SOX4/MTHFR | 4 |
| GO:0051402 | Neuron apoptotic process | 5/86 | 245/18866 | 0.005259584 | 0.075535237 | 0.06123397 | GATA3/GABRB3/TGFB2/BDNF/TP63 | 5 |
| GO:0010869 | Regulation of receptor biosynthetic process | 2/86 | 24/18866 | 0.005311093 | 0.075818242 | 0.061463393 | ITGAV/ITGB3 | 2 |
| GO:0050708 | Regulation of protein secretion | 6/86 | 352/18866 | 0.005437537 | 0.076277029 | 0.061835316 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0000288 | Nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3/86 | 78/18866 | 0.005439218 | 0.076277029 | 0.061835316 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0060395 | SMAD protein signal transduction | 3/86 | 78/18866 | 0.005439218 | 0.076277029 | 0.061835316 | SMAD6/TGFB2/INHBB | 3 |
| GO:0009636 | Response to toxic substance | 5/86 | 250/18866 | 0.005721706 | 0.079503569 | 0.064450968 | PPP1R9A/AHR/SLC7A11/ATP7A/TP53INP1 | 5 |
| GO:0010770 | Positive regulation of cell morphogenesis involved in differentiation | 4/86 | 157/18866 | 0.00577791 | 0.079503569 | 0.064450968 | SKIL/BDNF/BMPR2/NEDD9 | 4 |
| GO:0051017 | Actin filament bundle assembly | 4/86 | 157/18866 | 0.00577791 | 0.079503569 | 0.064450968 | PPP1R9A/CGNL1/ARHGAP28/NEDD9 | 4 |
| GO:0031667 | Response to nutrient levels | 7/86 | 473/18866 | 0.005832 | 0.079503569 | 0.064450968 | SORL1/NUAK1/MTHFR/SLC38A2/GABARAPL1/INHBB/BMPR2 | 7 |
| GO:0003151 | Outflow tract morphogenesis | 3/86 | 80/18866 | 0.005836042 | 0.079503569 | 0.064450968 | SMAD6/TGFB2/BMPR2 | 3 |
| GO:0031668 | Cellular response to extracellular stimulus | 5/86 | 253/18866 | 0.006012367 | 0.081440239 | 0.066020964 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0021884 | Forebrain neuron development | 2/86 | 26/18866 | 0.006217208 | 0.082775094 | 0.067103088 | SEMA3A/ATP7A | 2 |
| GO:1903649 | Regulation of cytoplasmic transport | 2/86 | 26/18866 | 0.006217208 | 0.082775094 | 0.067103088 | SORL1/MAP2 | 2 |
| GO:0021954 | Central nervous system neuron development | 3/86 | 82/18866 | 0.006249797 | 0.082775094 | 0.067103088 | SEMA3A/ATP7A/MAP2 | 3 |
| GO:1903313 | Positive regulation of mRNA metabolic process | 3/86 | 82/18866 | 0.006249797 | 0.082775094 | 0.067103088 | CPEB3/TNRC6C/CNOT6L | 3 |
| GO:0061572 | Actin filament bundle organization | 4/86 | 161/18866 | 0.006308804 | 0.08305588 | 0.067330711 | PPP1R9A/CGNL1/ARHGAP28/NEDD9 | 4 |
| GO:0001667 | Ameboidal-type cell migration | 7/86 | 481/18866 | 0.006375514 | 0.08305588 | 0.067330711 | GATA3/SASH1/TGFB2/SEMA3A/HDAC9/BMPR2/ITGB3 | 7 |
| GO:0016569 | Covalent chromatin modification | 7/86 | 481/18866 | 0.006375514 | 0.08305588 | 0.067330711 | GATA3/RSF1/MTHFR/HDAC9/ATF7IP/TET2/JMJD1C | 7 |
| GO:2000146 | Negative regulation of cell motility | 6/86 | 365/18866 | 0.006461198 | 0.083286412 | 0.067517597 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:2000243 | Positive regulation of reproductive process | 3/86 | 83/18866 | 0.006463081 | 0.083286412 | 0.067517597 | SEMA3A/INHBB/PLCB1 | 3 |
| GO:0003007 | Heart morphogenesis | 5/86 | 258/18866 | 0.006519717 | 0.083564546 | 0.067743071 | GATA3/SMAD6/TGFB2/SOX4/BMPR2 | 5 |
| GO:0021537 | Telencephalon development | 5/86 | 259/18866 | 0.006624687 | 0.084002275 | 0.068097923 | SLC7A11/BCAN/SEMA3A/SLC38A2/PLCB1 | 5 |
| GO:0050769 | Positive regulation of neurogenesis | 7/86 | 485/18866 | 0.006661076 | 0.084002275 | 0.068097923 | CPEB3/PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/PACSIN1 | 7 |
| GO:0007214 | Gamma-aminobutyric acid signaling pathway | 2/86 | 27/18866 | 0.006694812 | 0.084002275 | 0.068097923 | GABRB3/BDNF | 2 |
| GO:0072337 | Modified amino acid transport | 2/86 | 27/18866 | 0.006694812 | 0.084002275 | 0.068097923 | SLC7A11/SLC38A2 | 2 |
| GO:0007611 | Learning or memory | 5/86 | 260/18866 | 0.006730839 | 0.084012142 | 0.068105922 | CPEB3/SLC7A11/ATXN1/BDNF/PLCB1 | 5 |
| GO:0014910 | Regulation of smooth muscle cell migration | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SORL1/ATP7A/PRKG1 | 3 |
| GO:0034109 | Homotypic cell-cell adhesion | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0050772 | Positive regulation of axonogenesis | 3/86 | 86/18866 | 0.007128822 | 0.086118398 | 0.069813396 | SKIL/BDNF/BMPR2 | 3 |
| GO:1902903 | Regulation of supramolecular fiber organization | 6/86 | 373/18866 | 0.007157109 | 0.086118398 | 0.069813396 | PPP1R9A/CGNL1/TTBK2/ARHGAP28/JMY/MAP2 | 6 |
| GO:0003180 | Aortic valve morphogenesis | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | GATA3/SMAD6 | 2 |
| GO:0031440 | Regulation of mRNA 3′-end processing | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | CPEB3/CCNT1 | 2 |
| GO:0032800 | Receptor biosynthetic process | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | ITGAV/ITGB3 | 2 |
| GO:0080111 | DNA demethylation | 2/86 | 28/18866 | 0.007188574 | 0.086118398 | 0.069813396 | GATA3/TET2 | 2 |
| GO:0032874 | Positive regulation of stress-activated MAPK cascade | 4/86 | 170/18866 | 0.007619707 | 0.090826908 | 0.073630433 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0042634 | Regulation of hair cycle | 2/86 | 29/18866 | 0.007698341 | 0.091302546 | 0.074016017 | FST/TGFB2 | 2 |
| GO:0022604 | Regulation of cell morphogenesis | 7/86 | 499/18866 | 0.007736206 | 0.091302546 | 0.074016017 | PPP1R9A/SKIL/BDNF/SEMA3A/BMPR2/MAP2/NEDD9 | 7 |
| GO:0045666 | Positive regulation of neuron differentiation | 6/86 | 380/18866 | 0.007809358 | 0.091370068 | 0.074070754 | CPEB3/PPP1R9A/SKIL/BDNF/BMPR2/PACSIN1 | 6 |
| GO:0002791 | Regulation of peptide secretion | 6/86 | 381/18866 | 0.007905929 | 0.091370068 | 0.074070754 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0050714 | Positive regulation of protein secretion | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | SORL1/TGFB2/SOX4/MYO18A | 4 |
| GO:0070304 | Positive regulation of stress-activated protein kinase signaling cascade | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:1990138 | Neuron projection extension | 4/86 | 172/18866 | 0.007933559 | 0.091370068 | 0.074070754 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0045682 | Regulation of epidermis development | 3/86 | 91/18866 | 0.008325904 | 0.094971077 | 0.076989976 | FST/TGFB2/TP63 | 3 |
| GO:0051492 | Regulation of stress fiber assembly | 3/86 | 91/18866 | 0.008325904 | 0.094971077 | 0.076989976 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0060292 | Long-term synaptic depression | 2/86 | 31/18866 | 0.008765276 | 0.099506758 | 0.080666905 | PPP1R9A/SLC24A1 | 2 |
| GO:0045778 | Positive regulation of ossification | 3/86 | 94/18866 | 0.009097485 | 0.102722925 | 0.083274148 | TGFB2/BMPR2/TP63 | 3 |
| GO:1901796 | Regulation of signal transduction by p53 class mediator | 4/86 | 180/18866 | 0.009273809 | 0.102722925 | 0.083274148 | NUAK1/JMY/TP53INP1/TP63 | 4 |
| GO:0010743 | Regulation of macrophage derived foam cell differentiation | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | ITGAV/ITGB3 | 2 |
| GO:0048841 | Regulation of axon extension involved in axon guidance | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | SEMA3A/BMPR2 | 2 |
| GO:0061157 | mRNA destabilization | 2/86 | 32/18866 | 0.009322144 | 0.102722925 | 0.083274148 | CPEB3/CNOT6L | 2 |
| GO:0030198 | Extracellular matrix organization | 6/86 | 395/18866 | 0.009350199 | 0.102722925 | 0.083274148 | COL8A1/TGFB2/BCAN/ATP7A/ITGAV/ITGB3 | 6 |
| GO:0050678 | Regulation of epithelial cell proliferation | 6/86 | 395/18866 | 0.009350199 | 0.102722925 | 0.083274148 | GATA3/TGFB2/ATP7A/BMPR2/ITGB3/TP63 | 6 |
| GO:0043062 | Extracellular structure organization | 6/86 | 396/18866 | 0.009460121 | 0.103453798 | 0.083866643 | COL8A1/TGFB2/BCAN/ATP7A/ITGAV/ITGB3 | 6 |
| GO:0001822 | Kidney development | 5/86 | 283/18866 | 0.009514131 | 0.103569356 | 0.083960322 | GATA3/SMAD6/TGFB2/SOX4/BDNF | 5 |
| GO:0040013 | Negative regulation of locomotion | 6/86 | 397/18866 | 0.009570966 | 0.103635943 | 0.084014302 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:0090288 | Negative regulation of cellular response to growth factor stimulus | 4/86 | 182/18866 | 0.009630517 | 0.103635943 | 0.084014302 | SORL1/GATA3/SKIL/SMAD6 | 4 |
| GO:0007411 | Axon guidance | 5/86 | 284/18866 | 0.009650662 | 0.103635943 | 0.084014302 | GATA3/ETV1/BDNF/SEMA3A/BMPR2 | 5 |
| GO:0097485 | Neuron projection guidance | 5/86 | 285/18866 | 0.00978854 | 0.103806173 | 0.084152302 | GATA3/ETV1/BDNF/SEMA3A/BMPR2 | 5 |
| GO:0055001 | Muscle cell development | 4/86 | 183/18866 | 0.009812177 | 0.103806173 | 0.084152302 | NEBL/PGM5/HDAC9/ANK2 | 4 |
| GO:2000758 | Positive regulation of peptidyllysine acetylation | 2/86 | 33/18866 | 0.00989441 | 0.103806173 | 0.084152302 | GATA3/SOX4 | 2 |
| GO:0051271 | Negative regulation of cellular component movement | 6/86 | 400/18866 | 0.009909083 | 0.103806173 | 0.084152302 | GATA3/CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 6 |
| GO:0030516 | Regulation of axon extension | 3/86 | 97/18866 | 0.009909621 | 0.103806173 | 0.084152302 | SEMA3A/BMPR2/MAP2 | 3 |
| GO:0043542 | Endothelial cell migration | 5/86 | 286/18866 | 0.009927772 | 0.103806173 | 0.084152302 | GATA3/SASH1/HDAC9/BMPR2/ITGB3 | 5 |
| GO:0007416 | Synapse assembly | 4/86 | 184/18866 | 0.009996053 | 0.104063714 | 0.084361082 | PPP1R9A/GABRB3/BDNF/SLITRK6 | 4 |
| GO:0001657 | Ureteric bud development | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | GATA3/SMAD6/BDNF | 3 |
| GO:0006835 | Dicarboxylic acid transport | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0044728 | DNA methylation or demethylation | 3/86 | 98/18866 | 0.010189417 | 0.104705042 | 0.084880986 | GATA3/ATF7IP/TET2 | 3 |
| GO:0072163 | Mesonephric epithelium development | 3/86 | 99/18866 | 0.010473779 | 0.105981576 | 0.085915831 | GATA3/SMAD6/BDNF | 3 |
| GO:0072164 | Mesonephric tubule development | 3/86 | 99/18866 | 0.010473779 | 0.105981576 | 0.085915831 | GATA3/SMAD6/BDNF | 3 |
| GO:0035510 | DNA dealkylation | 2/86 | 34/18866 | 0.010481928 | 0.105981576 | 0.085915831 | GATA3/TET2 | 2 |
| GO:0018205 | Peptidyl-lysine modification | 6/86 | 405/18866 | 0.010491465 | 0.105981576 | 0.085915831 | GATA3/RSF1/SOX4/ATP7A/HDAC9/TET2 | 6 |
| GO:0072001 | Renal system development | 5/86 | 292/18866 | 0.010791921 | 0.108556703 | 0.088003403 | GATA3/SMAD6/TGFB2/SOX4/BDNF | 5 |
| GO:0007369 | Gastrulation | 4/86 | 189/18866 | 0.010949043 | 0.108906117 | 0.088286661 | COL8A1/ITGAV/BMPR2/ITGB3 | 4 |
| GO:0007435 | Salivary gland morphogenesis | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | TGFB2/SEMA3A | 2 |
| GO:0035909 | Aorta morphogenesis | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | TGFB2/SOX4 | 2 |
| GO:0050779 | RNA destabilization | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | CPEB3/CNOT6L | 2 |
| GO:0070306 | Lens fiber cell differentiation | 2/86 | 35/18866 | 0.01108455 | 0.108906117 | 0.088286661 | SLC7A11/SKIL | 2 |
| GO:0006575 | Cellular modified amino acid metabolic process | 4/86 | 190/18866 | 0.011146431 | 0.108906117 | 0.088286661 | SLC7A11/GATA3/MTHFR/CHAC1 | 4 |
| GO:0030308 | Negative regulation of cell growth | 4/86 | 190/18866 | 0.011146431 | 0.108906117 | 0.088286661 | TGFB2/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0048167 | Regulation of synaptic plasticity | 4/86 | 191/18866 | 0.011346106 | 0.110036081 | 0.089202686 | CPEB3/PPP1R9A/SLC24A1/BDNF | 4 |
| GO:0110020 | Regulation of actomyosin structure organization | 3/86 | 102/18866 | 0.011354394 | 0.110036081 | 0.089202686 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0021953 | Central nervous system neuron differentiation | 4/86 | 192/18866 | 0.011548076 | 0.111010541 | 0.089992649 | SOX4/SEMA3A/ATP7A/MAP2 | 4 |
| GO:0044272 | Sulfur compound biosynthetic process | 4/86 | 192/18866 | 0.011548076 | 0.111010541 | 0.089992649 | SLC7A11/BCAN/MTHFR/CHAC1 | 4 |
| GO:0001823 | Mesonephros development | 3/86 | 103/18866 | 0.011657152 | 0.111591497 | 0.090463612 | GATA3/SMAD6/BDNF | 3 |
| GO:0071634 | Regulation of transforming growth factor beta production | 2/86 | 36/18866 | 0.011702128 | 0.111591497 | 0.090463612 | TGFB2/ITGAV | 2 |
| GO:0002793 | Positive regulation of peptide secretion | 4/86 | 193/18866 | 0.011752352 | 0.111623928 | 0.090489903 | SORL1/TGFB2/SOX4/MYO18A | 4 |
| GO:0010639 | Negative regulation of organelle organization | 6/86 | 416/18866 | 0.011857924 | 0.112179729 | 0.090940473 | PPP1R9A/CGNL1/USP30/TTBK2/ARHGAP28/MAP2 | 6 |
| GO:0032231 | Regulation of actin filament bundle assembly | 3/86 | 104/18866 | 0.011964538 | 0.112740945 | 0.091395432 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0048846 | Axon extension involved in axon guidance | 2/86 | 37/18866 | 0.012334518 | 0.11495818 | 0.093192873 | SEMA3A/BMPR2 | 2 |
| GO:1902284 | Neuron projection extension involved in neuron projection guidance | 2/86 | 37/18866 | 0.012334518 | 0.11495818 | 0.093192873 | SEMA3A/BMPR2 | 2 |
| GO:0050890 | Cognition | 5/86 | 302/18866 | 0.012344503 | 0.11495818 | 0.093192873 | CPEB3/SLC7A11/ATXN1/BDNF/PLCB1 | 5 |
| GO:0001841 | Neural tube formation | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | TGFB2/SOX4/MTHFR | 3 |
| GO:0030038 | Contractile actin filament bundle assembly | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0032091 | Negative regulation of protein binding | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | SORL1/TTBK2/MAP2 | 3 |
| GO:0034446 | Substrate adhesion-dependent cell spreading | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | ITGAV/NEDD9/ITGB3 | 3 |
| GO:0043149 | Stress fiber assembly | 3/86 | 106/18866 | 0.012593245 | 0.11502795 | 0.093249434 | PPP1R9A/CGNL1/ARHGAP28 | 3 |
| GO:0051963 | Regulation of synapse assembly | 3/86 | 107/18866 | 0.012914585 | 0.116346145 | 0.094318051 | PPP1R9A/BDNF/SLITRK6 | 3 |
| GO:0007223 | Wnt signaling pathway, calcium modulating pathway | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | PLCB1/TNRC6C | 2 |
| GO:0010742 | Macrophage derived foam cell differentiation | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | ITGAV/ITGB3 | 2 |
| GO:0071604 | Transforming growth factor beta production | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | TGFB2/ITGAV | 2 |
| GO:0090077 | Foam cell differentiation | 2/86 | 38/18866 | 0.012981575 | 0.116346145 | 0.094318051 | ITGAV/ITGB3 | 2 |
| GO:0007229 | Integrin-mediated signaling pathway | 3/86 | 108/18866 | 0.013240598 | 0.117782039 | 0.095482084 | ITGAV/NEDD9/ITGB3 | 3 |
| GO:0008593 | Regulation of Notch signaling pathway | 3/86 | 108/18866 | 0.013240598 | 0.117782039 | 0.095482084 | TGFB2/CHAC1/TP63 | 3 |
| GO:0001662 | Behavioral fear response | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | FBXL20/BDNF | 2 |
| GO:0007431 | Salivary gland development | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | TGFB2/SEMA3A | 2 |
| GO:0031111 | Negative regulation of microtubule polymerization or depolymerization | 2/86 | 39/18866 | 0.013643155 | 0.120019487 | 0.097295911 | TTBK2/MAP2 | 2 |
| GO:0090100 | Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3/86 | 110/18866 | 0.013906677 | 0.121887936 | 0.098810602 | TGFB2/INHBB/BMPR2 | 3 |
| GO:0050808 | Synapse organization | 6/86 | 433/18866 | 0.01421063 | 0.122354017 | 0.099188438 | PPP1R9A/SLC7A11/GABRB3/BCAN/BDNF/SLITRK6 | 6 |
| GO:1903532 | Positive regulation of secretion by cell | 5/86 | 313/18866 | 0.014220651 | 0.122354017 | 0.099188438 | SORL1/TGFB2/SOX4/MYO18A/INHBB | 5 |
| GO:0000096 | Sulfur amino acid metabolic process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | SLC7A11/MTHFR | 2 |
| GO:0002209 | Behavioral defense response | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | FBXL20/BDNF | 2 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | GATA3/TGFB2 | 2 |
| GO:0042417 | Dopamine metabolic process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | TGFB2/ATP7A | 2 |
| GO:0043902 | Positive regulation of multi-organism process | 2/86 | 40/18866 | 0.014319115 | 0.122354017 | 0.099188438 | INHBB/PLCB1 | 2 |
| GO:0098656 | Anion transmembrane transport | 5/86 | 315/18866 | 0.014581278 | 0.123355537 | 0.100000338 | SLC7A11/CLIC4/SLC24A1/GABRB3/SLC38A2 | 5 |
| GO:0010927 | Cellular component assembly involved in morphogenesis | 3/86 | 112/18866 | 0.014591553 | 0.123355537 | 0.100000338 | NEBL/PGM5/ANK2 | 3 |
| GO:0099565 | Chemical synaptic transmission, postsynaptic | 3/86 | 112/18866 | 0.014591553 | 0.123355537 | 0.100000338 | PPP1R9A/GABRB3/BDNF | 3 |
| GO:0007009 | Plasma membrane organization | 3/86 | 113/18866 | 0.014941059 | 0.125112608 | 0.101424739 | TGFB2/ANK2/PACSIN1 | 3 |
| GO:0042596 | Fear response | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | FBXL20/BDNF | 2 |
| GO:0050434 | Positive regulation of viral transcription | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | CCNT1/RSF1 | 2 |
| GO:2000826 | Regulation of heart morphogenesis | 2/86 | 41/18866 | 0.015009315 | 0.125112608 | 0.101424739 | TGFB2/BMPR2 | 2 |
| GO:0043200 | Response to amino acid | 3/86 | 114/18866 | 0.015295288 | 0.127052153 | 0.102997065 | CPEB3/MTHFR/ATP7A | 3 |
| GO:0043393 | Regulation of protein binding | 4/86 | 211/18866 | 0.015833518 | 0.13061283 | 0.105883591 | SORL1/BDNF/TTBK2/MAP2 | 4 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | 4/86 | 211/18866 | 0.015833518 | 0.13061283 | 0.105883591 | ATP7A/BMPR2/ITGB3/TP63 | 4 |
| GO:0030278 | Regulation of ossification | 4/86 | 212/18866 | 0.016083232 | 0.131760911 | 0.106814303 | SMAD6/TGFB2/BMPR2/TP63 | 4 |
| GO:1901215 | Negative regulation of neuron death | 4/86 | 212/18866 | 0.016083232 | 0.131760911 | 0.106814303 | SORL1/SLC7A11/GABRB3/BDNF | 4 |
| GO:0030517 | Negative regulation of axon extension | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | SEMA3A/MAP2 | 2 |
| GO:0040019 | Positive regulation of embryonic development | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | GATA3/PLCB1 | 2 |
| GO:0060119 | Inner ear receptor cell development | 2/86 | 43/18866 | 0.016431868 | 0.133243447 | 0.108016147 | GABRB3/SLITRK6 | 2 |
| GO:0043523 | Regulation of neuron apoptotic process | 4/86 | 214/18866 | 0.016590079 | 0.134070337 | 0.108686479 | GATA3/GABRB3/TGFB2/BDNF | 4 |
| GO:0071496 | Cellular response to external stimulus | 5/86 | 326/18866 | 0.016675122 | 0.134302338 | 0.108874555 | NUAK1/SLC38A2/GABARAPL1/INHBB/BMPR2 | 5 |
| GO:0046660 | Female sex differentiation | 3/86 | 119/18866 | 0.017137505 | 0.135942997 | 0.110204584 | FST/INHBB/TP63 | 3 |
| GO:0045684 | Positive regulation of epidermis development | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | FST/TGFB2 | 2 |
| GO:0060999 | Positive regulation of dendritic spine development | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | CPEB3/PPP1R9A | 2 |
| GO:1901985 | Positive regulation of protein acetylation | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | GATA3/SOX4 | 2 |
| GO:1902667 | Regulation of axon guidance | 2/86 | 44/18866 | 0.017163944 | 0.135942997 | 0.110204584 | SEMA3A/BMPR2 | 2 |
| GO:0006304 | DNA modification | 3/86 | 120/18866 | 0.017520203 | 0.137848726 | 0.111749497 | GATA3/ATF7IP/TET2 | 3 |
| GO:0051588 | Regulation of neurotransmitter transport | 3/86 | 120/18866 | 0.017520203 | 0.137848726 | 0.111749497 | PPP1R9A/FBXL20/ITGB3 | 3 |
| GO:0006338 | Chromatin remodeling | 4/86 | 218/18866 | 0.017633653 | 0.138177114 | 0.11201571 | GATA3/RSF1/ATF7IP/TP63 | 4 |
| GO:0060562 | Epithelial tube morphogenesis | 5/86 | 331/18866 | 0.017689868 | 0.138177114 | 0.11201571 | GATA3/CLIC4/TGFB2/SOX4/MTHFR | 5 |
| GO:0002065 | Columnar/cuboidal epithelial cell differentiation | 3/86 | 121/18866 | 0.017907664 | 0.138177114 | 0.11201571 | SOX4/SLITRK6/TP63 | 3 |
| GO:0001974 | Blood vessel remodeling | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | ATP7A/BMPR2 | 2 |
| GO:0003197 | Endocardial cushion development | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | TGFB2/BMPR2 | 2 |
| GO:0014047 | Glutamate secretion | 2/86 | 45/18866 | 0.017909701 | 0.138177114 | 0.11201571 | BDNF/SLC38A2 | 2 |
| GO:0007163 | Establishment or maintenance of cell polarity | 4/86 | 220/18866 | 0.01817049 | 0.139736926 | 0.1132802 | GATA3/CLIC4/MYO18A/MAP2 | 4 |
| GO:0097237 | Cellular response to toxic substance | 3/86 | 122/18866 | 0.018299893 | 0.140279566 | 0.1137201 | PPP1R9A/ATP7A/TP53INP1 | 3 |
| GO:0032570 | Response to progesterone | 2/86 | 46/18866 | 0.018669004 | 0.142194587 | 0.115272545 | NCOA2/TGFB2 | 2 |
| GO:0035987 | Endodermal cell differentiation | 2/86 | 46/18866 | 0.018669004 | 0.142194587 | 0.115272545 | COL8A1/ITGAV | 2 |
| GO:0009306 | Protein secretion | 6/86 | 462/18866 | 0.018947479 | 0.143856018 | 0.116619414 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0022612 | Gland morphogenesis | 3/86 | 124/18866 | 0.019098668 | 0.144306981 | 0.116984995 | TGFB2/SEMA3A/TP63 | 3 |
| GO:0035592 | Establishment of protein localization to extracellular region | 6/86 | 463/18866 | 0.019127939 | 0.144306981 | 0.116984995 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:0006378 | mRNA polyadenylation | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | CPEB3/CCNT1 | 2 |
| GO:0032369 | Negative regulation of lipid transport | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ITGAV/ITGB3 | 2 |
| GO:0060986 | Endocrine hormone secretion | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | GATA3/INHBB | 2 |
| GO:1904738 | Vascular associated smooth muscle cell migration | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ATP7A/PRKG1 | 2 |
| GO:1904752 | Regulation of vascular associated smooth muscle cell migration | 2/86 | 47/18866 | 0.019441716 | 0.144389565 | 0.117051943 | ATP7A/PRKG1 | 2 |
| GO:0016570 | Histone modification | 6/86 | 468/18866 | 0.02004796 | 0.148094346 | 0.120055289 | GATA3/RSF1/MTHFR/HDAC9/TET2/JMJD1C | 6 |
| GO:0009101 | Glycoprotein biosynthetic process | 5/86 | 342/18866 | 0.020064796 | 0.148094346 | 0.120055289 | BCAN/ATP7A/BMPR2/PLCB1/TET2 | 5 |
| GO:0043631 | RNA polyadenylation | 2/86 | 48/18866 | 0.020227701 | 0.148835926 | 0.120656465 | CPEB3/CCNT1 | 2 |
| GO:0007596 | Blood coagulation | 5/86 | 343/18866 | 0.020290572 | 0.14883915 | 0.120659078 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0071692 | Protein localization to extracellular region | 6/86 | 470/18866 | 0.0204243 | 0.149360526 | 0.12108174 | SORL1/TGFB2/SOX4/HDAC9/MYO18A/INHBB | 6 |
| GO:1903311 | Regulation of mRNA metabolic process | 5/86 | 344/18866 | 0.020518013 | 0.149586983 | 0.121265322 | CPEB3/CCNT1/MBNL2/TNRC6C/CNOT6L | 5 |
| GO:0050807 | Regulation of synapse organization | 4/86 | 229/18866 | 0.020712003 | 0.150540902 | 0.122038633 | PPP1R9A/SLC7A11/BDNF/SLITRK6 | 4 |
| GO:0015695 | Organic cation transport | 2/86 | 49/18866 | 0.021026827 | 0.151902896 | 0.123142758 | SLC38A2/ITGB3 | 2 |
| GO:0042398 | Cellular modified amino acid biosynthetic process | 2/86 | 49/18866 | 0.021026827 | 0.151902896 | 0.123142758 | SLC7A11/CHAC1 | 2 |
| GO:0032271 | Regulation of protein polymerization | 4/86 | 231/18866 | 0.021305014 | 0.153447596 | 0.124394996 | PPP1R9A/ARHGAP28/JMY/MAP2 | 4 |
| GO:0007599 | Hemostasis | 5/86 | 348/18866 | 0.021444515 | 0.153987119 | 0.12483237 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0050817 | Coagulation | 5/86 | 349/18866 | 0.021680346 | 0.154492818 | 0.125242323 | SLC7A11/GATA3/PRKG1/JMJD1C/ITGB3 | 5 |
| GO:0008544 | Epidermis development | 6/86 | 477/18866 | 0.02177946 | 0.154492818 | 0.125242323 | FST/CLIC4/TGFB2/ATP7A/SLITRK6/TP63 | 6 |
| GO:0008038 | Neuron recognition | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | BDNF/SEMA3A | 2 |
| GO:0021695 | Cerebellar cortex development | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | ATP7A/TTBK2 | 2 |
| GO:0043616 | Keratinocyte proliferation | 2/86 | 50/18866 | 0.02183896 | 0.154492818 | 0.125242323 | FST/TP63 | 2 |
| GO:0030336 | Negative regulation of cell migration | 5/86 | 350/18866 | 0.021917868 | 0.1545923 | 0.12532297 | CLIC4/SEMA3A/PLCB1/PRKG1/TP53INP1 | 5 |
| GO:0045667 | Regulation of osteoblast differentiation | 3/86 | 131/18866 | 0.022045008 | 0.155030383 | 0.12567811 | SMAD6/BMPR2/TP63 | 3 |
| GO:0001101 | Response to acid chemical | 3/86 | 132/18866 | 0.022485065 | 0.155708635 | 0.126227947 | CPEB3/MTHFR/ATP7A | 3 |
| GO:0042476 | Odontogenesis | 3/86 | 132/18866 | 0.022485065 | 0.155708635 | 0.126227947 | FST/TGFB2/TP63 | 3 |
| GO:0045444 | Fat cell differentiation | 4/86 | 235/18866 | 0.022522167 | 0.155708635 | 0.126227947 | GATA3/SMAD6/INHBB/PLCB1 | 4 |
| GO:0048638 | Regulation of developmental growth | 5/86 | 353/18866 | 0.022640619 | 0.155708635 | 0.126227947 | BDNF/SEMA3A/BMPR2/PLCB1/MAP2 | 5 |
| GO:0021545 | Cranial nerve development | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | SEMA3A/SLITRK6 | 2 |
| GO:0021879 | Forebrain neuron differentiation | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | SEMA3A/ATP7A | 2 |
| GO:0035272 | Exocrine system development | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | TGFB2/SEMA3A | 2 |
| GO:0043277 | Apoptotic cell clearance | 2/86 | 51/18866 | 0.022663967 | 0.155708635 | 0.126227947 | ITGAV/ITGB3 | 2 |
| GO:0060560 | Developmental growth involved in morphogenesis | 4/86 | 236/18866 | 0.022832971 | 0.156325812 | 0.126728272 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0051222 | Positive regulation of protein transport | 5/86 | 354/18866 | 0.022884945 | 0.156325812 | 0.126728272 | SORL1/TGFB2/SOX4/MYO18A/TP63 | 5 |
| GO:0032872 | Regulation of stress-activated MAPK cascade | 4/86 | 237/18866 | 0.023146391 | 0.157210815 | 0.127445716 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0048588 | Developmental cell growth | 4/86 | 237/18866 | 0.023146391 | 0.157210815 | 0.127445716 | BDNF/SEMA3A/BMPR2/MAP2 | 4 |
| GO:0007498 | Mesoderm development | 3/86 | 134/18866 | 0.023379551 | 0.158271449 | 0.128305537 | BMPR2/ITGB3/TP63 | 3 |
| GO:0034249 | Negative regulation of cellular amide metabolic process | 4/86 | 238/18866 | 0.023462432 | 0.158271449 | 0.128305537 | SORL1/CPEB3/TNRC6C/CNOT6L | 4 |
| GO:0010883 | Regulation of lipid storage | 2/86 | 52/18866 | 0.023501717 | 0.158271449 | 0.128305537 | ITGAV/ITGB3 | 2 |
| GO:0050803 | Regulation of synapse structure or activity | 4/86 | 240/18866 | 0.024102395 | 0.161152503 | 0.130641115 | PPP1R9A/SLC7A11/BDNF/SLITRK6 | 4 |
| GO:0070302 | Regulation of stress-activated protein kinase signaling cascade | 4/86 | 240/18866 | 0.024102395 | 0.161152503 | 0.130641115 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0031589 | Cell-substrate adhesion | 5/86 | 359/18866 | 0.024132317 | 0.161152503 | 0.130641115 | COL8A1/SMAD6/ITGAV/NEDD9/ITGB3 | 5 |
| GO:0042073 | Intraciliary transport | 2/86 | 53/18866 | 0.02435208 | 0.162165805 | 0.131462566 | RABL2B/LCA5 | 2 |
| GO:0006749 | Glutathione metabolic process | 2/86 | 54/18866 | 0.025214926 | 0.167052167 | 0.135423781 | SLC7A11/CHAC1 | 2 |
| GO:0046330 | Positive regulation of JNK cascade | 3/86 | 138/18866 | 0.025225998 | 0.167052167 | 0.135423781 | SASH1/SEMA3A/PLCB1 | 3 |
| GO:0001706 | Endoderm formation | 2/86 | 55/18866 | 0.026090127 | 0.171820063 | 0.139288959 | COL8A1/ITGAV | 2 |
| GO:0030199 | Collagen fibril organization | 2/86 | 55/18866 | 0.026090127 | 0.171820063 | 0.139288959 | TGFB2/ATP7A | 2 |
| GO:0008584 | Male gonad development | 3/86 | 141/18866 | 0.026661088 | 0.174456189 | 0.141425982 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0030010 | Establishment of cell polarity | 3/86 | 141/18866 | 0.026661088 | 0.174456189 | 0.141425982 | GATA3/MYO18A/MAP2 | 3 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | SOX4/CNOT6L | 2 |
| GO:0044273 | Sulfur compound catabolic process | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | BCAN/CHAC1 | 2 |
| GO:0060563 | Neuroepithelial cell differentiation | 2/86 | 56/18866 | 0.026977555 | 0.174456189 | 0.141425982 | SOX4/SLITRK6 | 2 |
| GO:1904951 | Positive regulation of establishment of protein localization | 5/86 | 370/18866 | 0.027029446 | 0.174456189 | 0.141425982 | SORL1/TGFB2/SOX4/MYO18A/TP63 | 5 |
| GO:0031333 | Negative regulation of protein-containing complex assembly | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | SORL1/SMAD6/MAP2 | 3 |
| GO:0046546 | Development of primary male sexual characteristics | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0072073 | Kidney epithelium development | 3/86 | 142/18866 | 0.027149013 | 0.174456189 | 0.141425982 | GATA3/SMAD6/BDNF | 3 |
| GO:0016571 | Histone methylation | 3/86 | 143/18866 | 0.027641714 | 0.176752565 | 0.143287579 | GATA3/MTHFR/TET2 | 3 |
| GO:0045747 | Positive regulation of Notch signaling pathway | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | TGFB2/TP63 | 2 |
| GO:0051568 | Histone H3-K4 methylation | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | GATA3/TET2 | 2 |
| GO:0072431 | Signal transduction involved in mitotic G1 DNA damage checkpoint | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | SOX4/CNOT6L | 2 |
| GO:1902400 | Intracellular signal transduction involved in G1 DNA damage checkpoint | 2/86 | 57/18866 | 0.027877082 | 0.176752565 | 0.143287579 | SOX4/CNOT6L | 2 |
| GO:0060078 | Regulation of postsynaptic membrane potential | 3/86 | 144/18866 | 0.028139189 | 0.177941187 | 0.144251156 | PPP1R9A/GABRB3/BDNF | 3 |
| GO:0045926 | Negative regulation of growth | 4/86 | 254/18866 | 0.02887904 | 0.181656023 | 0.147262653 | TGFB2/SEMA3A/BMPR2/MAP2 | 4 |
| GO:2000027 | Regulation of animal organ morphogenesis | 4/86 | 254/18866 | 0.02887904 | 0.181656023 | 0.147262653 | GATA3/TGFB2/BDNF/BMPR2 | 4 |
| GO:0048813 | Dendrite morphogenesis | 3/86 | 146/18866 | 0.029148446 | 0.182868148 | 0.148245284 | PPP1R9A/SEMA3A/MAP2 | 3 |
| GO:0050707 | Regulation of cytokine secretion | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SORL1/HDAC9 | 2 |
| GO:0051058 | Negative regulation of small GTPase mediated signal transduction | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | CGNL1/TGFB2 | 2 |
| GO:0060113 | Inner ear receptor cell differentiation | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | GABRB3/SLITRK6 | 2 |
| GO:0072413 | Signal transduction involved in mitotic cell cycle checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:1902402 | Signal transduction involved in mitotic DNA damage checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:1902403 | Signal transduction involved in mitotic DNA integrity checkpoint | 2/86 | 59/18866 | 0.029711935 | 0.183505836 | 0.148762237 | SOX4/CNOT6L | 2 |
| GO:0042093 | T-helper cell differentiation | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | GATA3/ATP7A | 2 |
| GO:0048747 | Muscle fiber development | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | NEBL/HDAC9 | 2 |
| GO:0061098 | Positive regulation of protein tyrosine kinase activity | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | BDNF/NEDD9 | 2 |
| GO:0097755 | Positive regulation of blood vessel diameter | 2/86 | 60/18866 | 0.03064701 | 0.187339672 | 0.151870204 | BMPR2/PRKG1 | 2 |
| GO:0035107 | Appendage morphogenesis | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | TGFB2/SOX4/TP63 | 3 |
| GO:0035108 | Limb morphogenesis | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | TGFB2/SOX4/TP63 | 3 |
| GO:0060041 | Retina development in camera-type eye | 3/86 | 150/18866 | 0.031224077 | 0.189410176 | 0.153548695 | CLIC4/TGFB2/BMPR2 | 3 |
| GO:0021872 | Forebrain generation of neurons | 2/86 | 61/18866 | 0.031593687 | 0.190681897 | 0.154579637 | SEMA3A/ATP7A | 2 |
| GO:2000756 | Regulation of peptidyl-lysine acetylation | 2/86 | 61/18866 | 0.031593687 | 0.190681897 | 0.154579637 | GATA3/SOX4 | 2 |
| GO:0050684 | Regulation of mRNA processing | 3/86 | 152/18866 | 0.032290377 | 0.194394591 | 0.157589398 | CPEB3/CCNT1/MBNL2 | 3 |
| GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 2/86 | 62/18866 | 0.032551842 | 0.194858921 | 0.157965815 | GATA3/ATP7A | 2 |
| GO:0034113 | Heterotypic cell-cell adhesion | 2/86 | 62/18866 | 0.032551842 | 0.194858921 | 0.157965815 | ITGAV/ITGB3 | 2 |
| GO:0048863 | Stem cell differentiation | 4/86 | 264/18866 | 0.032612714 | 0.194858921 | 0.157965815 | GATA3/TGFB2/SEMA3A/TP63 | 4 |
| GO:0042692 | Muscle cell differentiation | 5/86 | 390/18866 | 0.032848287 | 0.195775793 | 0.158709094 | NEBL/PGM5/BDNF/HDAC9/ANK2 | 5 |
| GO:0002287 | Alpha-beta T cell activation involved in immune response | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | GATA3/ATP7A | 2 |
| GO:0002293 | Alpha-beta T cell differentiation involved in immune response | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | GATA3/ATP7A | 2 |
| GO:0010830 | Regulation of myotube differentiation | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | BDNF/HDAC9 | 2 |
| GO:0031571 | Mitotic G1 DNA damage checkpoint | 2/86 | 63/18866 | 0.033521355 | 0.197809181 | 0.160357496 | SOX4/CNOT6L | 2 |
| GO:0050773 | Regulation of dendrite development | 3/86 | 155/18866 | 0.033925312 | 0.199698629 | 0.16188921 | CPEB3/PPP1R9A/PACSIN1 | 3 |
| GO:0006865 | Amino acid transport | 3/86 | 156/18866 | 0.03447973 | 0.200587288 | 0.162609617 | SLC7A11/BDNF/SLC38A2 | 3 |
| GO:0043484 | Regulation of RNA splicing | 3/86 | 156/18866 | 0.03447973 | 0.200587288 | 0.162609617 | MBNL2/SLC38A2/AHNAK2 | 3 |
| GO:0030166 | Proteoglycan biosynthetic process | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | BCAN/BMPR2 | 2 |
| GO:0044783 | G1 DNA damage checkpoint | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | SOX4/CNOT6L | 2 |
| GO:0044819 | Mitotic G1/S transition checkpoint | 2/86 | 64/18866 | 0.034502103 | 0.200587288 | 0.162609617 | SOX4/CNOT6L | 2 |
| GO:0090596 | Sensory organ morphogenesis | 4/86 | 269/18866 | 0.034581114 | 0.200587288 | 0.162609617 | COL8A1/GATA3/BDNF/SLITRK6 | 4 |
| GO:0045787 | Positive regulation of cell cycle | 5/86 | 396/18866 | 0.034735534 | 0.200993965 | 0.162939297 | CCNT1/TGFB2/SOX4/PLCB1/CNOT6L | 5 |
| GO:0046782 | Regulation of viral transcription | 2/86 | 65/18866 | 0.035493968 | 0.204390387 | 0.165692666 | CCNT1/RSF1 | 2 |
| GO:1905953 | Negative regulation of lipid localization | 2/86 | 65/18866 | 0.035493968 | 0.204390387 | 0.165692666 | ITGAV/ITGB3 | 2 |
| GO:0030168 | Platelet activation | 3/86 | 158/18866 | 0.035602685 | 0.20452241 | 0.165799693 | SLC7A11/PRKG1/ITGB3 | 3 |
| GO:0032922 | Circadian regulation of gene expression | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | AHR/NCOA2 | 2 |
| GO:0034394 | Protein localization to cell surface | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | BDNF/ANK2 | 2 |
| GO:0045669 | Positive regulation of osteoblast differentiation | 2/86 | 66/18866 | 0.03649683 | 0.208154171 | 0.168743844 | BMPR2/TP63 | 2 |
| GO:0045927 | Positive regulation of growth | 4/86 | 274/18866 | 0.03661755 | 0.208344248 | 0.168897933 | TGFB2/BDNF/BMPR2/PLCB1 | 4 |
| GO:0010970 | Transport along microtubule | 3/86 | 161/18866 | 0.037322311 | 0.211407097 | 0.171380886 | RABL2B/LCA5/MAP2 | 3 |
| GO:0030239 | Myofibril assembly | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | NEBL/PGM5 | 2 |
| GO:0031060 | Regulation of histone methylation | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | GATA3/MTHFR | 2 |
| GO:0051965 | Positive regulation of synapse assembly | 2/86 | 67/18866 | 0.037510571 | 0.211407097 | 0.171380886 | BDNF/SLITRK6 | 2 |
| GO:0032970 | Regulation of actin filament-based process | 5/86 | 405/18866 | 0.037690922 | 0.211922541 | 0.17179874 | PPP1R9A/CGNL1/ARHGAP28/ANK2/JMY | 5 |
| GO:0110053 | Regulation of actin filament organization | 4/86 | 278/18866 | 0.038295803 | 0.213645618 | 0.173195582 | PPP1R9A/CGNL1/ARHGAP28/JMY | 4 |
| GO:0021915 | Neural tube development | 3/86 | 163/18866 | 0.038492103 | 0.213645618 | 0.173195582 | TGFB2/SOX4/MTHFR | 3 |
| GO:0072577 | Endothelial cell apoptotic process | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | GATA3/BMPR2 | 2 |
| GO:0098840 | Protein transport along microtubule | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | RABL2B/LCA5 | 2 |
| GO:0099118 | Microtubule-based protein transport | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | RABL2B/LCA5 | 2 |
| GO:1904888 | Cranial skeletal system development | 2/86 | 68/18866 | 0.038535074 | 0.213645618 | 0.173195582 | TGFB2/TP63 | 2 |
| GO:0001764 | Neuron migration | 3/86 | 164/18866 | 0.039083988 | 0.215208675 | 0.174462702 | GATA3/SEMA3A/PRKG1 | 3 |
| GO:0046661 | Male sex differentiation | 3/86 | 164/18866 | 0.039083988 | 0.215208675 | 0.174462702 | GATA3/TGFB2/SEMA3A | 3 |
| GO:0071230 | Cellular response to amino acid stimulus | 2/86 | 69/18866 | 0.039570221 | 0.215208675 | 0.174462702 | CPEB3/ATP7A | 2 |
| GO:1903317 | Regulation of protein maturation | 2/86 | 69/18866 | 0.039570221 | 0.215208675 | 0.174462702 | SOX4/CHAC1 | 2 |
| GO:1903531 | Negative regulation of secretion by cell | 3/86 | 166/18866 | 0.040281693 | 0.215208675 | 0.174462702 | PPP1R9A/HDAC9/INHBB | 3 |
| GO:2001233 | Regulation of apoptotic signaling pathway | 5/86 | 413/18866 | 0.040444458 | 0.215208675 | 0.174462702 | SKIL/BDNF/ITGAV/INHBB/TP63 | 5 |
| GO:0009880 | Embryonic pattern specification | 2/86 | 70/18866 | 0.040615897 | 0.215208675 | 0.174462702 | SMAD6/SEMA3A | 2 |
| GO:0050771 | Negative regulation of axonogenesis | 2/86 | 70/18866 | 0.040615897 | 0.215208675 | 0.174462702 | SEMA3A/MAP2 | 2 |
| GO:0009100 | Glycoprotein metabolic process | 5/86 | 415/18866 | 0.041151564 | 0.215208675 | 0.174462702 | BCAN/ATP7A/BMPR2/PLCB1/TET2 | 5 |
| GO:0002292 | T cell differentiation involved in immune response | 2/86 | 71/18866 | 0.041671986 | 0.215208675 | 0.174462702 | GATA3/ATP7A | 2 |
| GO:0051403 | Stress-activated MAPK cascade | 4/86 | 286/18866 | 0.041783498 | 0.215208675 | 0.174462702 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0055002 | Striated muscle cell development | 3/86 | 169/18866 | 0.042112957 | 0.215208675 | 0.174462702 | NEBL/PGM5/HDAC9 | 3 |
| GO:2000241 | Regulation of reproductive process | 3/86 | 170/18866 | 0.042732596 | 0.215208675 | 0.174462702 | SEMA3A/INHBB/PLCB1 | 3 |
| GO:0050663 | Cytokine secretion | 2/86 | 72/18866 | 0.042738376 | 0.215208675 | 0.174462702 | SORL1/HDAC9 | 2 |
| GO:0001558 | Regulation of cell growth | 5/86 | 420/18866 | 0.042952231 | 0.215208675 | 0.174462702 | TGFB2/BDNF/SEMA3A/BMPR2/MAP2 | 5 |
| GO:0030307 | Positive regulation of cell growth | 3/86 | 171/18866 | 0.043356828 | 0.215208675 | 0.174462702 | TGFB2/BDNF/BMPR2 | 3 |
| GO:0060485 | Mesenchyme development | 4/86 | 290/18866 | 0.043592995 | 0.215208675 | 0.174462702 | GATA3/TGFB2/SEMA3A/BMPR2 | 4 |
| GO:0097193 | Intrinsic apoptotic signaling pathway | 4/86 | 290/18866 | 0.043592995 | 0.215208675 | 0.174462702 | SKIL/CHAC1/JMY/TP63 | 4 |
| GO:0015807 | l-amino acid transport | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SLC7A11/SLC38A2 | 2 |
| GO:0072401 | Signal transduction involved in DNA integrity checkpoint | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0072422 | Signal transduction involved in DNA damage checkpoint | 2/86 | 73/18866 | 0.043814951 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0002244 | Hematopoietic progenitor cell differentiation | 3/86 | 172/18866 | 0.043985644 | 0.215208675 | 0.174462702 | FST/GATA3/SOX4 | 3 |
| GO:0018394 | Peptidyl-lysine acetylation | 3/86 | 172/18866 | 0.043985644 | 0.215208675 | 0.174462702 | GATA3/RSF1/SOX4 | 3 |
| GO:0021543 | Pallium development | 3/86 | 173/18866 | 0.044619032 | 0.215208675 | 0.174462702 | BCAN/SLC38A2/PLCB1 | 3 |
| GO:0002524 | Hypersensitivity | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0003149 | Membranous septum morphogenesis | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0003211 | Cardiac ventricle formation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0010603 | Regulation of cytoplasmic mRNA processing body assembly | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | CNOT6L | 1 |
| GO:0021562 | Vestibulocochlear nerve development | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SLITRK6 | 1 |
| GO:0021859 | Pyramidal neuron differentiation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0032025 | Response to cobalt ion | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0032926 | Negative regulation of activin receptor signaling pathway | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | FST | 1 |
| GO:0035860 | Glial cell-derived neurotrophic factor receptor signaling pathway | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0035871 | Protein K11-linked deubiquitination | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | USP30 | 1 |
| GO:0035999 | Tetrahydrofolate interconversion | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | MTHFR | 1 |
| GO:0042428 | Serotonin metabolic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0044557 | Relaxation of smooth muscle | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | PRKG1 | 1 |
| GO:0045793 | Positive regulation of cell size | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0048251 | Elastic fiber assembly | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0051541 | Elastin metabolic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0060513 | Prostatic bud formation | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0060600 | Dichotomous subdivision of an epithelial terminal unit | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | ANK2 | 1 |
| GO:0090527 | Actin filament reorganization | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | NEDD9 | 1 |
| GO:1902946 | Protein localization to early endosome | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:1904672 | Regulation of somatic stem cell population maintenance | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:1904684 | Negative regulation of metalloendopeptidase activity | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:2000018 | Regulation of male gonad development | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:2000271 | Positive regulation of fibroblast apoptotic process | 1/86 | 10/18866 | 0.044671283 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0043588 | Skin development | 5/86 | 425/18866 | 0.044800039 | 0.215208675 | 0.174462702 | FST/CLIC4/TGFB2/ATP7A/TP63 | 5 |
| GO:0072395 | Signal transduction involved in cell cycle checkpoint | 2/86 | 74/18866 | 0.0449016 | 0.215208675 | 0.174462702 | SOX4/CNOT6L | 2 |
| GO:0030833 | Regulation of actin filament polymerization | 3/86 | 174/18866 | 0.045256984 | 0.215208675 | 0.174462702 | PPP1R9A/ARHGAP28/JMY | 3 |
| GO:0010921 | Regulation of phosphatase activity | 3/86 | 175/18866 | 0.045899487 | 0.215208675 | 0.174462702 | NUAK1/SYTL2/TGFB2 | 3 |
| GO:0050768 | Negative regulation of neurogenesis | 4/86 | 295/18866 | 0.045916409 | 0.215208675 | 0.174462702 | SORL1/BDNF/SEMA3A/MAP2 | 4 |
| GO:0051146 | Striated muscle cell differentiation | 4/86 | 295/18866 | 0.045916409 | 0.215208675 | 0.174462702 | NEBL/PGM5/BDNF/HDAC9 | 4 |
| GO:0001707 | Mesoderm formation | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | BMPR2/ITGB3 | 2 |
| GO:0035019 | Somatic stem cell population maintenance | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | SOX4/TP63 | 2 |
| GO:0043627 | Response to estrogen | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | GATA3/SMAD6 | 2 |
| GO:1901983 | Regulation of protein acetylation | 2/86 | 75/18866 | 0.045998211 | 0.215208675 | 0.174462702 | GATA3/SOX4 | 2 |
| GO:0033555 | Multicellular organismal response to stress | 2/86 | 76/18866 | 0.047104673 | 0.215208675 | 0.174462702 | FBXL20/BDNF | 2 |
| GO:0071229 | Cellular response to acid chemical | 2/86 | 76/18866 | 0.047104673 | 0.215208675 | 0.174462702 | CPEB3/ATP7A | 2 |
| GO:0030324 | Lung development | 3/86 | 177/18866 | 0.047198109 | 0.215208675 | 0.174462702 | SLC7A11/ATP7A/BMPR2 | 3 |
| GO:0048771 | Tissue remodeling | 3/86 | 178/18866 | 0.047854205 | 0.215208675 | 0.174462702 | ATP7A/BMPR2/ITGB3 | 3 |
| GO:0007422 | Peripheral nervous system development | 2/86 | 77/18866 | 0.048220875 | 0.215208675 | 0.174462702 | ETV1/BDNF | 2 |
| GO:0048332 | Mesoderm morphogenesis | 2/86 | 77/18866 | 0.048220875 | 0.215208675 | 0.174462702 | BMPR2/ITGB3 | 2 |
| GO:0034329 | Cell junction assembly | 5/86 | 434/18866 | 0.048245354 | 0.215208675 | 0.174462702 | PPP1R9A/GABRB3/BDNF/ANK2/SLITRK6 | 5 |
| GO:0031098 | Stress-activated protein kinase signaling cascade | 4/86 | 300/18866 | 0.048308144 | 0.215208675 | 0.174462702 | SASH1/TGFB2/SEMA3A/PLCB1 | 4 |
| GO:0051258 | Protein polymerization | 4/86 | 300/18866 | 0.048308144 | 0.215208675 | 0.174462702 | PPP1R9A/ARHGAP28/JMY/MAP2 | 4 |
| GO:0002182 | Cytoplasmic translational elongation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:0002328 | Pro-B cell differentiation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0006751 | Glutathione catabolic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CHAC1 | 1 |
| GO:0006857 | Oligopeptide transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0009950 | Dorsal/ventral axis specification | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SMAD6 | 1 |
| GO:0021561 | Facial nerve development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0021604 | Cranial nerve structural organization | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0021610 | Facial nerve morphogenesis | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SEMA3A | 1 |
| GO:0031442 | Positive regulation of mRNA 3′-end processing | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:0032253 | Dense core granule localization | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:0032276 | Regulation of gonadotropin secretion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | INHBB | 1 |
| GO:0032754 | Positive regulation of interleukin-5 production | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0034776 | Response to histamine | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GABRB3 | 1 |
| GO:0035457 | Cellular response to interferon-alpha | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0043455 | Regulation of secondary metabolic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0043589 | Skin morphogenesis | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0044848 | Biological phase | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0046643 | Regulation of gamma-delta T cell activation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0048021 | Regulation of melanin biosynthetic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:0048102 | Autophagic cell death | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP53INP1 | 1 |
| GO:0048103 | Somatic stem cell division | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TGFB2 | 1 |
| GO:0048672 | Positive regulation of collateral sprouting | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | BDNF | 1 |
| GO:0048742 | Regulation of skeletal muscle fiber development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | HDAC9 | 1 |
| GO:0051610 | Serotonin uptake | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ITGB3 | 1 |
| GO:0060174 | Limb bud formation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SOX4 | 1 |
| GO:0060525 | Prostate glandular acinus development | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | TP63 | 1 |
| GO:0061085 | Regulation of histone H3-K27 methylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0061299 | Retina vasculature morphogenesis in camera-type eye | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CLIC4 | 1 |
| GO:0070254 | Mucus secretion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SYTL2 | 1 |
| GO:0070933 | Histone H4 deacetylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | HDAC9 | 1 |
| GO:0071281 | Cellular response to iron ion | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ATP7A | 1 |
| GO:0090084 | Negative regulation of inclusion body assembly | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:0090309 | Positive regulation of DNA methylation-dependent heterochromatin assembly | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | ATF7IP | 1 |
| GO:0099519 | Dense core granule cytoskeletal transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1900247 | Regulation of cytoplasmic translational elongation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | CPEB3 | 1 |
| GO:1900376 | Regulation of secondary metabolite biosynthetic process | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SLC7A11 | 1 |
| GO:1901950 | Dense core granule transport | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1902513 | Regulation of organelle transport along microtubule | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:1904321 | Response to forskolin | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | AHR | 1 |
| GO:1904322 | Cellular response to forskolin | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | AHR | 1 |
| GO:1905245 | Regulation of aspartic-type peptidase activity | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | SORL1 | 1 |
| GO:2000551 | Regulation of T-helper 2 cell cytokine production | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:2000574 | Regulation of microtubule motor activity | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | MAP2 | 1 |
| GO:2000615 | Regulation of histone H3-K9 acetylation | 1/86 | 11/18866 | 0.049028425 | 0.215208675 | 0.174462702 | GATA3 | 1 |
| GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | GATA3/ATP7A | 2 |
| GO:0043900 | Regulation of multi-organism process | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | INHBB/PLCB1 | 2 |
| GO:0060998 | Regulation of dendritic spine development | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | CPEB3/PPP1R9A | 2 |
| GO:0072332 | Intrinsic apoptotic signaling pathway by p53 class mediator | 2/86 | 78/18866 | 0.049346708 | 0.215208675 | 0.174462702 | JMY/TP63 | 2 |
| GO:1903522 | Regulation of blood circulation | 4/86 | 303/18866 | 0.049775935 | 0.215208675 | 0.174462702 | TGFB2/SEMA3A/ANK2/BMPR2 | 4 |
| GO:0030323 | Respiratory tube development | 3/86 | 181/18866 | 0.049849498 | 0.215208675 | 0.174462702 | SLC7A11/ATP7A/BMPR2 | 3 |
Table S2.
Functional enrichment analysis (MF) of genes associated with the downregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0031994 | Insulin-like growth factor I binding | 2/87 | 13/18352 | 0.001675018 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0003712 | Transcription coregulator activity | 8/87 | 498/18352 | 0.002489608 | 0.273507638 | 0.253388116 | GATA3/NCOA2/RSF1/SOX4/HDAC9/ATF7IP/JMY/JMJD1C | 8 |
| GO:0017134 | Fibroblast growth factor binding | 2/87 | 23/18352 | 0.005268487 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0005160 | Transforming growth factor beta receptor binding | 2/87 | 24/18352 | 0.005729821 | 0.273507638 | 0.253388116 | SMAD6/TGFB2 | 2 |
| GO:0005546 | Phosphatidylinositol-4,5-bisphosphate binding | 3/87 | 82/18352 | 0.006959505 | 0.273507638 | 0.253388116 | SYTL2/SESTD1/PLCB1 | 3 |
| GO:0001968 | Fibronectin binding | 2/87 | 27/18352 | 0.007220079 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0005520 | Insulin-like growth factor binding | 2/87 | 29/18352 | 0.008300389 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0005126 | Cytokine receptor binding | 5/87 | 271/18352 | 0.009355786 | 0.273507638 | 0.253388116 | GATA3/SMAD6/TGFB2/BDNF/ITGB3 | 5 |
| GO:0019956 | Chemokine binding | 2/87 | 33/18352 | 0.010663192 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0015175 | Neutral amino acid transmembrane transporter activity | 2/87 | 34/18352 | 0.011295035 | 0.273507638 | 0.253388116 | SLC7A11/SLC38A2 | 2 |
| GO:0008022 | Protein C-terminus binding | 4/87 | 189/18352 | 0.012493832 | 0.273507638 | 0.253388116 | PPP1R9A/MAGI1/SASH1/ATXN1 | 4 |
| GO:0051015 | Actin filament binding | 4/87 | 206/18352 | 0.016646672 | 0.273507638 | 0.253388116 | PPP1R9A/NEBL/MYO18A/CLMN | 4 |
| GO:1902936 | Phosphatidylinositol bisphosphate binding | 3/87 | 119/18352 | 0.018993105 | 0.273507638 | 0.253388116 | SYTL2/SESTD1/PLCB1 | 3 |
| GO:0048156 | Tau protein binding | 2/87 | 45/18352 | 0.019274238 | 0.273507638 | 0.253388116 | TTBK2/MAP2 | 2 |
| GO:0015026 | Coreceptor activity | 2/87 | 48/18352 | 0.021761265 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0016538 | Cyclin-dependent protein serine/threonine kinase regulator activity | 2/87 | 50/18352 | 0.023489237 | 0.273507638 | 0.253388116 | CCNT1/CCNG2 | 2 |
| GO:0070888 | E-box binding | 2/87 | 50/18352 | 0.023489237 | 0.273507638 | 0.253388116 | AHR/GATA3 | 2 |
| GO:0022853 | Active ion transmembrane transporter activity | 4/87 | 229/18352 | 0.023508097 | 0.273507638 | 0.253388116 | SLC7A11/SLC24A1/ATP7A/SLC38A2 | 4 |
| GO:0019955 | Cytokine binding | 3/87 | 135/18352 | 0.026361093 | 0.273507638 | 0.253388116 | ITGAV/BMPR2/ITGB3 | 3 |
| GO:0019838 | Growth factor binding | 3/87 | 136/18352 | 0.026865607 | 0.273507638 | 0.253388116 | ITGAV/BMPR2/ITGB3 | 3 |
| GO:0008509 | Anion transmembrane transporter activity | 5/87 | 357/18352 | 0.027380166 | 0.273507638 | 0.253388116 | SLC7A11/CLIC4/SLC24A1/GABRB3/SLC38A2 | 5 |
| GO:0005080 | Protein kinase C binding | 2/87 | 55/18352 | 0.028045437 | 0.273507638 | 0.253388116 | HDAC9/ITGAV | 2 |
| GO:0050840 | Extracellular matrix binding | 2/87 | 57/18352 | 0.029959408 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0015179 | l-amino acid transmembrane transporter activity | 2/87 | 59/18352 | 0.031923969 | 0.273507638 | 0.253388116 | SLC7A11/SLC38A2 | 2 |
| GO:0003713 | Transcription coactivator activity | 4/87 | 267/18352 | 0.038154759 | 0.273507638 | 0.253388116 | GATA3/NCOA2/SOX4/JMY | 4 |
| GO:0002039 | p53 binding | 2/87 | 66/18352 | 0.039182529 | 0.273507638 | 0.253388116 | NUAK1/TP63 | 2 |
| GO:0008083 | Growth factor activity | 3/87 | 162/18352 | 0.041782078 | 0.273507638 | 0.253388116 | TGFB2/BDNF/INHBB | 3 |
| GO:0072509 | Divalent inorganic cation transmembrane transporter activity | 3/87 | 162/18352 | 0.041782078 | 0.273507638 | 0.253388116 | SLC24A1/ATP7A/ITGAV | 3 |
| GO:0001094 | TFIID-class transcription factor complex binding | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | AHR | 1 |
| GO:0002162 | Dystroglycan binding | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | MAP2 | 1 |
| GO:0004690 | Cyclic nucleotide-dependent protein kinase activity | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | PRKG1 | 1 |
| GO:0005432 | Calcium:sodium antiporter activity | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | SLC24A1 | 1 |
| GO:0016868 | Intramolecular transferase activity, phosphotransferases | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | PGM2L1 | 1 |
| GO:0017002 | Activin-activated receptor activity | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | BMPR2 | 1 |
| GO:0030957 | Tat protein binding | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | GABARAPL1 | 1 |
| GO:0031078 | Histone deacetylase activity (H3-K14 specific) | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | HDAC9 | 1 |
| GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific) | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | HDAC9 | 1 |
| GO:0140104 | Molecular carrier activity | 1/87 | 10/18352 | 0.046418788 | 0.273507638 | 0.253388116 | ATP7A | 1 |
| GO:0001618 | Virus receptor activity | 2/87 | 74/18352 | 0.048161835 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0140272 | Exogenous protein binding | 2/87 | 74/18352 | 0.048161835 | 0.273507638 | 0.253388116 | ITGAV/ITGB3 | 2 |
| GO:0005254 | Chloride channel activity | 2/87 | 75/18352 | 0.049332465 | 0.273507638 | 0.253388116 | CLIC4/GABRB3 | 2 |
Table S3.
Functional enrichment analysis (CC) of downregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0043034 | Costamere | 3/89 | 19/19559 | 8.37177E-05 | 0.018250458 | 0.013835451 | PGM5/ANK2/AHNAK2 | 3 |
| GO:0042641 | Actomyosin | 4/89 | 79/19559 | 0.000463912 | 0.036256484 | 0.027485601 | NEBL/PGM5/LPP/MYO18A | 4 |
| GO:0098858 | Actin-based cell projection | 6/89 | 220/19559 | 0.000505501 | 0.036256484 | 0.027485601 | PPP1R9A/CLIC4/ATP7A/ITGAV/MAP2/ITGB3 | 6 |
| GO:0031252 | Cell leading edge | 8/89 | 421/19559 | 0.000665257 | 0.036256484 | 0.027485601 | PPP1R9A/ATP7A/ITGAV/GABARAPL1/PACSIN1/JMY/NEDD9/ITGB3 | 8 |
| GO:0005902 | Microvillus | 4/89 | 93/19559 | 0.000858959 | 0.037450592 | 0.02839084 | CLIC4/ATP7A/ITGAV/ITGB3 | 4 |
| GO:0044214 | Spanning component of plasma membrane | 2/89 | 12/19559 | 0.001311795 | 0.043519068 | 0.032991278 | SLC24A1/BMPR2 | 2 |
| GO:0030175 | Filopodium | 4/89 | 106/19559 | 0.001397401 | 0.043519068 | 0.032991278 | PPP1R9A/ITGAV/MAP2/ITGB3 | 4 |
| GO:0030014 | CCR4-NOT complex | 2/89 | 16/19559 | 0.002357022 | 0.052272891 | 0.039627445 | CPEB3/CNOT6L | 2 |
| GO:0030018 | Z disc | 4/89 | 128/19559 | 0.002782162 | 0.052272891 | 0.039627445 | NEBL/PGM5/ANK2/AHNAK2 | 4 |
| GO:0031527 | Filopodium membrane | 2/89 | 18/19559 | 0.002987491 | 0.052272891 | 0.039627445 | ITGAV/ITGB3 | 2 |
| GO:0097440 | Apical dendrite | 2/89 | 18/19559 | 0.002987491 | 0.052272891 | 0.039627445 | CPEB3/MAP2 | 2 |
| GO:0089717 | Spanning component of membrane | 2/89 | 19/19559 | 0.003329111 | 0.052272891 | 0.039627445 | SLC24A1/BMPR2 | 2 |
| GO:0042383 | Sarcolemma | 4/89 | 135/19559 | 0.003369092 | 0.052272891 | 0.039627445 | PGM5/ANK2/SLC38A2/AHNAK2 | 4 |
| GO:0001725 | Stress fiber | 3/89 | 68/19559 | 0.003687104 | 0.052272891 | 0.039627445 | NEBL/PGM5/LPP | 3 |
| GO:0097517 | Contractile actin filament bundle | 3/89 | 68/19559 | 0.003687104 | 0.052272891 | 0.039627445 | NEBL/PGM5/LPP | 3 |
| GO:0031674 | I band | 4/89 | 140/19559 | 0.003836542 | 0.052272891 | 0.039627445 | NEBL/PGM5/ANK2/AHNAK2 | 4 |
| GO:0031258 | Lamellipodium membrane | 2/89 | 22/19559 | 0.004457567 | 0.057161747 | 0.043333628 | ITGAV/ITGB3 | 2 |
| GO:0031253 | Cell projection membrane | 6/89 | 344/19559 | 0.004845054 | 0.057814402 | 0.043828397 | SLC7A11/ATP7A/ITGAV/GABARAPL1/PACSIN1/ITGB3 | 6 |
| GO:0032432 | Actin filament bundle | 3/89 | 76/19559 | 0.00503887 | 0.057814402 | 0.043828397 | NEBL/PGM5/LPP | 3 |
| GO:0031528 | Microvillus membrane | 2/89 | 26/19559 | 0.006197936 | 0.067557503 | 0.051214524 | ITGAV/ITGB3 | 2 |
| GO:0005911 | Cell-cell junction | 7/89 | 493/19559 | 0.007222799 | 0.074979535 | 0.056841077 | MAGI1/CGNL1/CLIC4/PGM5/ANK2/BMPR2/ITGB3 | 7 |
| GO:0031256 | Leading edge membrane | 4/89 | 175/19559 | 0.008381702 | 0.082823288 | 0.062787331 | ITGAV/GABARAPL1/PACSIN1/ITGB3 | 4 |
| GO:0008305 | Integrin complex | 2/89 | 31/19559 | 0.008738237 | 0.082823288 | 0.062787331 | ITGAV/ITGB3 | 2 |
| GO:0032587 | Ruffle membrane | 3/89 | 95/19559 | 0.009326562 | 0.08471627 | 0.064222378 | ITGAV/PACSIN1/ITGB3 | 3 |
| GO:0032839 | Dendrite cytoplasm | 2/89 | 34/19559 | 0.010449687 | 0.091121271 | 0.069077931 | GABARAPL1/MAP2 | 2 |
| GO:0098636 | Protein complex involved in cell adhesion | 2/89 | 36/19559 | 0.011666204 | 0.097816632 | 0.074153603 | ITGAV/ITGB3 | 2 |
| GO:0005903 | Brush border | 3/89 | 106/19559 | 0.012543653 | 0.10127838 | 0.076777912 | SLC7A11/ATP7A/SLC38A2 | 3 |
| GO:0030027 | Lamellipodium | 4/89 | 201/19559 | 0.013409681 | 0.104403946 | 0.079147366 | PPP1R9A/ITGAV/NEDD9/ITGB3 | 4 |
| GO:0030017 | Sarcomere | 4/89 | 207/19559 | 0.014792138 | 0.111196071 | 0.084296394 | NEBL/PGM5/ANK2/AHNAK2 | 4 |
| GO:0000307 | Cyclin-dependent protein kinase holoenzyme complex | 2/89 | 43/19559 | 0.016381768 | 0.119040851 | 0.090243426 | CCNT1/CCNG2 | 2 |
| GO:0030016 | Myofibril | 4/89 | 227/19559 | 0.020039059 | 0.140919836 | 0.106829619 | NEBL/PGM5/ANK2/AHNAK2 | 4 |
| GO:0034707 | Chloride channel complex | 2/89 | 50/19559 | 0.021772834 | 0.144876464 | 0.109829091 | CLIC4/GABRB3 | 2 |
| GO:0034399 | Nuclear periphery | 3/89 | 131/19559 | 0.021959481 | 0.144876464 | 0.109829091 | CLIC4/ATXN1/MAP2 | 3 |
| GO:0014704 | Intercalated disc | 2/89 | 51/19559 | 0.022595412 | 0.144876464 | 0.109829091 | PGM5/ANK2 | 2 |
| GO:0043292 | Contractile fiber | 4/89 | 238/19559 | 0.023357656 | 0.145484828 | 0.110290285 | NEBL/PGM5/ANK2/AHNAK2 | 4 |
| GO:0098978 | Glutamatergic synapse | 5/89 | 361/19559 | 0.024523154 | 0.147057064 | 0.111482178 | PPP1R9A/FBXL20/BCAN/PLCB1/ITGB3 | 5 |
| GO:0030315 | T-tubule | 2/89 | 54/19559 | 0.025138884 | 0.147057064 | 0.111482178 | ANK2/AHNAK2 | 2 |
| GO:0005802 | Trans-Golgi network | 4/89 | 245/19559 | 0.0256338 | 0.147057064 | 0.111482178 | SORL1/ATP7A/MYO18A/CHAC1 | 4 |
| GO:0016459 | Myosin complex | 2/89 | 57/19559 | 0.027793265 | 0.155357222 | 0.117774427 | CGNL1/MYO18A | 2 |
| GO:0031526 | Brush border membrane | 2/89 | 58/19559 | 0.028702113 | 0.156426515 | 0.118585046 | SLC7A11/ATP7A | 2 |
| GO:0036064 | Ciliary basal body | 3/89 | 155/19559 | 0.033795659 | 0.175834844 | 0.133298264 | RABL2B/TTBK2/LCA5 | 3 |
| GO:0098862 | Cluster of actin-based cell projections | 3/89 | 159/19559 | 0.036033328 | 0.175834844 | 0.133298264 | SLC7A11/ATP7A/SLC38A2 | 3 |
| GO:0035869 | Ciliary transition zone | 2/89 | 68/19559 | 0.038420498 | 0.175834844 | 0.133298264 | TTBK2/LCA5 | 2 |
| GO:0005912 | Adherens junction | 3/89 | 166/19559 | 0.040128844 | 0.175834844 | 0.133298264 | MAGI1/PGM5/BMPR2 | 3 |
| GO:0005667 | Transcription regulator complex | 5/89 | 413/19559 | 0.040249424 | 0.175834844 | 0.133298264 | AHR/SKIL/SMAD6/HDAC9/ATF7IP | 5 |
| GO:0005925 | Focal adhesion | 5/89 | 415/19559 | 0.040953218 | 0.175834844 | 0.133298264 | PGM5/LPP/ITGAV/NEDD9/ITGB3 | 5 |
| GO:0030055 | Cell-substrate junction | 5/89 | 423/19559 | 0.043843336 | 0.175834844 | 0.133298264 | PGM5/LPP/ITGAV/NEDD9/ITGB3 | 5 |
| GO:0005641 | Nuclear envelope lumen | 1/89 | 10/19559 | 0.044592867 | 0.175834844 | 0.133298264 | SORL1 | 1 |
| GO:1990124 | Messenger ribonucleoprotein complex | 1/89 | 10/19559 | 0.044592867 | 0.175834844 | 0.133298264 | CPEB3 | 1 |
| GO:0044291 | Cell-cell contact zone | 2/89 | 74/19559 | 0.044768917 | 0.175834844 | 0.133298264 | PGM5/ANK2 | 2 |
| GO:0098982 | GABA-ergic synapse | 2/89 | 74/19559 | 0.044768917 | 0.175834844 | 0.133298264 | GABRB3/PLCB1 | 2 |
| GO:0045177 | Apical part of cell | 5/89 | 433/19559 | 0.047625364 | 0.175834844 | 0.133298264 | SLC7A11/CLIC4/ATP7A/ANK2/BMPR2 | 5 |
| GO:0000118 | Histone deacetylase complex | 2/89 | 77/19559 | 0.048078825 | 0.175834844 | 0.133298264 | HDAC9/JMJD1C | 2 |
| GO:0001726 | Ruffle | 3/89 | 179/19559 | 0.048332303 | 0.175834844 | 0.133298264 | ITGAV/PACSIN1/ITGB3 | 3 |
| GO:0031010 | ISWI-type complex | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | RSF1 | 1 |
| GO:0034992 | Microtubule organizing center attachment site | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | CLMN | 1 |
| GO:0034993 | Meiotic nuclear membrane microtubule tethering complex | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | CLMN | 1 |
| GO:0097470 | Ribbon synapse | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | PACSIN1 | 1 |
| GO:0106083 | Nuclear membrane protein complex | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | CLMN | 1 |
| GO:0106094 | Nuclear membrane microtubule tethering complex | 1/89 | 11/19559 | 0.048942513 | 0.175834844 | 0.133298264 | CLMN | 1 |
| GO:0016234 | Inclusion body | 2/89 | 78/19559 | 0.049201493 | 0.175834844 | 0.133298264 | ATXN1/KLF8 | 2 |
Table S4.
Functional enrichment analysis (KEGG) of genes associated with the downregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| hsa04350 | TGF-beta signaling pathway | 5/45 | 96/8223 | 0.00016491 | 0.022922444 | 0.02187223 | FST/SMAD6/TGFB2/INHBB/BMPR2 | 5 |
| hsa04919 | Thyroid hormone signaling pathway | 4/45 | 121/8223 | 0.004173019 | 0.290024833 | 0.276737062 | NCOA2/ITGAV/PLCB1/ITGB3 | 4 |
| hsa04727 | GABAergic synapse | 3/45 | 89/8223 | 0.012533392 | 0.426926226 | 0.407366183 | GABRB3/SLC38A2/GABARAPL1 | 3 |
| hsa05410 | Hypertrophic cardiomyopathy | 3/45 | 90/8223 | 0.012916633 | 0.426926226 | 0.407366183 | TGFB2/ITGAV/ITGB3 | 3 |
| hsa05414 | Dilated cardiomyopathy | 3/45 | 96/8223 | 0.015357058 | 0.426926226 | 0.407366183 | TGFB2/ITGAV/ITGB3 | 3 |
| hsa05205 | Proteoglycans in cancer | 4/45 | 205/8223 | 0.025196801 | 0.497873197 | 0.475062649 | TGFB2/ANK2/ITGAV/ITGB3 | 4 |
| hsa05206 | MicroRNAs in cancer | 5/45 | 310/8223 | 0.026240318 | 0.497873197 | 0.475062649 | TGFB2/SOX4/BMPR2/ITGB3/TP63 | 5 |
| hsa04611 | Platelet activation | 3/45 | 124/8223 | 0.029996051 | 0.497873197 | 0.475062649 | PLCB1/PRKG1/ITGB3 | 3 |
| hsa04068 | FoxO signaling pathway | 3/45 | 131/8223 | 0.034496116 | 0.497873197 | 0.475062649 | TGFB2/CCNG2/GABARAPL1 | 3 |
| hsa05418 | Fluid shear stress and atherosclerosis | 3/45 | 139/8223 | 0.040045963 | 0.497873197 | 0.475062649 | ITGAV/BMPR2/ITGB3 | 3 |
| hsa04730 | Long-term depression | 2/45 | 60/8223 | 0.04241652 | 0.497873197 | 0.475062649 | PLCB1/PRKG1 | 2 |
| hsa04550 | Signaling pathways regulating pluripotency of stem cells | 3/45 | 143/8223 | 0.042981859 | 0.497873197 | 0.475062649 | SKIL/INHBB/BMPR2 | 3 |
| hsa05321 | Inflammatory bowel disease | 2/45 | 65/8223 | 0.049000918 | 0.523932893 | 0.499928395 | GATA3/TGFB2 | 2 |
Table S5.
Functional enrichment analysis (BP) of the DEGs associated with the upregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0048660 | Regulation of smooth muscle cell proliferation | 5/38 | 173/18866 | 2.40386E-05 | 0.014098915 | 0.011725698 | TNFAIP3/APLN/IGFBP3/MYB/S1PR1 | 5 |
| GO:0048659 | Smooth muscle cell proliferation | 5/38 | 175/18866 | 2.54034E-05 | 0.014098915 | 0.011725698 | TNFAIP3/APLN/IGFBP3/MYB/S1PR1 | 5 |
| GO:0071222 | Cellular response to lipopolysaccharide | 5/38 | 208/18866 | 5.79563E-05 | 0.020270505 | 0.016858447 | CXCL3/PPBP/TNFAIP3/CXCL2/SERPINE1 | 5 |
| GO:0071219 | Cellular response to molecule of bacterial origin | 5/38 | 222/18866 | 7.88877E-05 | 0.020270505 | 0.016858447 | CXCL3/PPBP/TNFAIP3/CXCL2/SERPINE1 | 5 |
| GO:0030595 | Leukocyte chemotaxis | 5/38 | 232/18866 | 9.70957E-05 | 0.020270505 | 0.016858447 | CXCL3/PPBP/CXCL2/S1PR1/SERPINE1 | 5 |
| GO:0033002 | Muscle cell proliferation | 5/38 | 244/18866 | 0.000123037 | 0.020270505 | 0.016858447 | TNFAIP3/APLN/IGFBP3/MYB/S1PR1 | 5 |
| GO:0071216 | Cellular response to biotic stimulus | 5/38 | 246/18866 | 0.000127832 | 0.020270505 | 0.016858447 | CXCL3/PPBP/TNFAIP3/CXCL2/SERPINE1 | 5 |
| GO:0070424 | Regulation of nucleotide-binding oligomerization domain containing signaling pathway | 2/38 | 10/18866 | 0.000175971 | 0.024415911 | 0.020306073 | TNFAIP3/HSPA1B | 2 |
| GO:0061043 | Regulation of vascular wound healing | 2/38 | 13/18866 | 0.000303854 | 0.0350297 | 0.029133283 | TNFAIP3/SERPINE1 | 2 |
| GO:0070431 | Nucleotide-binding oligomerization domain containing 2 signaling pathway | 2/38 | 14/18866 | 0.000354046 | 0.0350297 | 0.029133283 | TNFAIP3/HSPA1B | 2 |
| GO:0048662 | Negative regulation of smooth muscle cell proliferation | 3/38 | 69/18866 | 0.000360371 | 0.0350297 | 0.029133283 | TNFAIP3/APLN/IGFBP3 | 3 |
| GO:0060326 | Cell chemotaxis | 5/38 | 311/18866 | 0.000378699 | 0.0350297 | 0.029133283 | CXCL3/PPBP/CXCL2/S1PR1/SERPINE1 | 5 |
| GO:0061844 | Antimicrobial humoral immune response mediated by antimicrobial peptide | 3/38 | 75/18866 | 0.000460592 | 0.039327508 | 0.032707657 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0032496 | Response to lipopolysaccharide | 5/38 | 334/18866 | 0.000524346 | 0.041184338 | 0.034251934 | CXCL3/PPBP/TNFAIP3/CXCL2/SERPINE1 | 5 |
| GO:0031397 | Negative regulation of protein ubiquitination | 3/38 | 80/18866 | 0.000556545 | 0.041184338 | 0.034251934 | TNFAIP3/DNAJA1/HSPA1B | 3 |
| GO:0002237 | Response to molecule of bacterial origin | 5/38 | 356/18866 | 0.000699847 | 0.048000435 | 0.039920704 | CXCL3/PPBP/TNFAIP3/CXCL2/SERPINE1 | 5 |
| GO:0070098 | Chemokine-mediated signaling pathway | 3/38 | 88/18866 | 0.000735142 | 0.048000435 | 0.039920704 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0061042 | Vascular wound healing | 2/38 | 21/18866 | 0.000809794 | 0.048876902 | 0.040649638 | TNFAIP3/SERPINE1 | 2 |
| GO:1903321 | Negative regulation of protein modification by small protein conjugation or removal | 3/38 | 92/18866 | 0.000836632 | 0.048876902 | 0.040649638 | TNFAIP3/DNAJA1/HSPA1B | 3 |
| GO:1990868 | Response to chemokine | 3/38 | 97/18866 | 0.000975483 | 0.050782909 | 0.042234813 | CXCL3/PPBP/CXCL2 | 3 |
| GO:1990869 | Cellular response to chemokine | 3/38 | 97/18866 | 0.000975483 | 0.050782909 | 0.042234813 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0097529 | Myeloid leukocyte migration | 4/38 | 222/18866 | 0.001006508 | 0.050782909 | 0.042234813 | CXCL3/PPBP/CXCL2/SERPINE1 | 4 |
| GO:0000079 | Regulation of cyclin-dependent protein serine/threonine kinase activity | 3/38 | 102/18866 | 0.001128148 | 0.053244499 | 0.044282054 | TNFAIP3/CDC25A/CDKN3 | 3 |
| GO:0030593 | Neutrophil chemotaxis | 3/38 | 103/18866 | 0.001160384 | 0.053244499 | 0.044282054 | CXCL3/PPBP/CXCL2 | 3 |
| GO:2001234 | Negative regulation of apoptotic signaling pathway | 4/38 | 233/18866 | 0.001203717 | 0.053244499 | 0.044282054 | TNFAIP3/DNAJA1/SERPINE1/HSPA1B | 4 |
| GO:1904029 | Regulation of cyclin-dependent protein kinase activity | 3/38 | 106/18866 | 0.001260569 | 0.053244499 | 0.044282054 | TNFAIP3/CDC25A/CDKN3 | 3 |
| GO:2001237 | Negative regulation of extrinsic apoptotic signaling pathway | 3/38 | 107/18866 | 0.001295136 | 0.053244499 | 0.044282054 | TNFAIP3/SERPINE1/HSPA1B | 3 |
| GO:0060055 | Angiogenesis involved in wound healing | 2/38 | 30/18866 | 0.001658373 | 0.065742634 | 0.054676425 | TNFAIP3/SERPINE1 | 2 |
| GO:1990266 | Neutrophil migration | 3/38 | 122/18866 | 0.001886881 | 0.072222009 | 0.060065151 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0071621 | Granulocyte chemotaxis | 3/38 | 127/18866 | 0.002115914 | 0.076192697 | 0.063367468 | CXCL3/PPBP/CXCL2 | 3 |
| GO:2000352 | Negative regulation of endothelial cell apoptotic process | 2/38 | 34/18866 | 0.002127904 | 0.076192697 | 0.063367468 | TNFAIP3/SERPINE1 | 2 |
| GO:0070423 | Nucleotide-binding oligomerization domain containing signaling pathway | 2/38 | 37/18866 | 0.002516584 | 0.084138903 | 0.069976119 | TNFAIP3/HSPA1B | 2 |
| GO:0019730 | Antimicrobial humoral response | 3/38 | 137/18866 | 0.002624222 | 0.084138903 | 0.069976119 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0014912 | Negative regulation of smooth muscle cell migration | 2/38 | 38/18866 | 0.002653028 | 0.084138903 | 0.069976119 | IGFBP3/SERPINE1 | 2 |
| GO:0035872 | Nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2/38 | 38/18866 | 0.002653028 | 0.084138903 | 0.069976119 | TNFAIP3/HSPA1B | 2 |
| GO:1902042 | Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 2/38 | 41/18866 | 0.003082827 | 0.095053839 | 0.079053785 | TNFAIP3/SERPINE1 | 2 |
| GO:0071901 | Negative regulation of protein serine/threonine kinase activity | 3/38 | 148/18866 | 0.003263895 | 0.096472101 | 0.080233317 | CHORDC1/TNFAIP3/DNAJA1 | 3 |
| GO:0045124 | Regulation of bone resorption | 2/38 | 43/18866 | 0.003386278 | 0.096472101 | 0.080233317 | TNFAIP3/S1PR1 | 2 |
| GO:0097530 | Granulocyte migration | 3/38 | 150/18866 | 0.00338956 | 0.096472101 | 0.080233317 | CXCL3/PPBP/CXCL2 | 3 |
| GO:1904036 | Negative regulation of epithelial cell apoptotic process | 2/38 | 48/18866 | 0.004203334 | 0.113869229 | 0.094702052 | TNFAIP3/SERPINE1 | 2 |
| GO:2001236 | Regulation of extrinsic apoptotic signaling pathway | 3/38 | 162/18866 | 0.004205981 | 0.113869229 | 0.094702052 | TNFAIP3/SERPINE1/HSPA1B | 3 |
| GO:0009408 | Response to heat | 3/38 | 166/18866 | 0.004502401 | 0.117537332 | 0.097752717 | CHORDC1/DNAJA1/HSPA1B | 3 |
| GO:0046850 | Regulation of bone remodeling | 2/38 | 50/18866 | 0.004553248 | 0.117537332 | 0.097752717 | TNFAIP3/S1PR1 | 2 |
| GO:0060976 | Coronary vasculature development | 2/38 | 51/18866 | 0.004733101 | 0.119403217 | 0.099304525 | ADAMTS6/APLN | 2 |
| GO:0048260 | Positive regulation of receptor-mediated endocytosis | 2/38 | 52/18866 | 0.004916199 | 0.121266244 | 0.100853955 | APLN/SERPINE1 | 2 |
| GO:0032757 | Positive regulation of interleukin-8 production | 2/38 | 54/18866 | 0.005292082 | 0.127700239 | 0.10620494 | SERPINE1/HSPA1B | 2 |
| GO:0062197 | Cellular response to chemical stress | 4/38 | 360/18866 | 0.005769905 | 0.135973274 | 0.113085407 | TNFAIP3/MYB/DNAJA1/HSPA1B | 4 |
| GO:0070936 | Protein K48-linked ubiquitination | 2/38 | 57/18866 | 0.005879925 | 0.135973274 | 0.113085407 | TNFAIP3/UBE2D4 | 2 |
| GO:0061077 | Chaperone-mediated protein folding | 2/38 | 60/18866 | 0.006496281 | 0.147160652 | 0.122389655 | CHORDC1/HSPA1B | 2 |
| GO:1902041 | Regulation of extrinsic apoptotic signaling pathway via death domain receptors | 2/38 | 61/18866 | 0.006708009 | 0.147776298 | 0.122901673 | TNFAIP3/SERPINE1 | 2 |
| GO:0010803 | Regulation of tumor necrosis factor-mediated signaling pathway | 2/38 | 62/18866 | 0.006922854 | 0.147776298 | 0.122901673 | TNFAIP3/HSPA1B | 2 |
| GO:2000351 | Regulation of endothelial cell apoptotic process | 2/38 | 62/18866 | 0.006922854 | 0.147776298 | 0.122901673 | TNFAIP3/SERPINE1 | 2 |
| GO:0045453 | Bone resorption | 2/38 | 64/18866 | 0.007361842 | 0.154181978 | 0.128229108 | TNFAIP3/S1PR1 | 2 |
| GO:0031331 | Positive regulation of cellular catabolic process | 4/38 | 390/18866 | 0.007622996 | 0.155713474 | 0.129502813 | TNFAIP3/TOMM7/PIM2/HSPA1B | 4 |
| GO:0030198 | Extracellular matrix organization | 4/38 | 395/18866 | 0.007965878 | 0.155713474 | 0.129502813 | ADAMTS6/ADAMTS14/SERPINE1/TGFBI | 4 |
| GO:0043062 | Extracellular structure organization | 4/38 | 396/18866 | 0.008035657 | 0.155713474 | 0.129502813 | ADAMTS6/ADAMTS14/SERPINE1/TGFBI | 4 |
| GO:0002753 | Cytoplasmic pattern recognition receptor signaling pathway | 2/38 | 68/18866 | 0.008276662 | 0.155713474 | 0.129502813 | TNFAIP3/HSPA1B | 2 |
| GO:0016239 | Positive regulation of macroautophagy | 2/38 | 68/18866 | 0.008276662 | 0.155713474 | 0.129502813 | TOMM7/PIM2 | 2 |
| GO:0072577 | Endothelial cell apoptotic process | 2/38 | 68/18866 | 0.008276662 | 0.155713474 | 0.129502813 | TNFAIP3/SERPINE1 | 2 |
| GO:0031396 | Regulation of protein ubiquitination | 3/38 | 211/18866 | 0.008724015 | 0.161394284 | 0.134227394 | TNFAIP3/DNAJA1/HSPA1B | 3 |
| GO:0001503 | Ossification | 4/38 | 412/18866 | 0.009207614 | 0.166220297 | 0.138241063 | CDH11/IGFBP3/STC1/S1PR1 | 4 |
| GO:2001233 | Regulation of apoptotic signaling pathway | 4/38 | 413/18866 | 0.009284377 | 0.166220297 | 0.138241063 | TNFAIP3/DNAJA1/SERPINE1/HSPA1B | 4 |
| GO:1903747 | Regulation of establishment of protein localization to mitochondrion | 2/38 | 73/18866 | 0.009488233 | 0.167173623 | 0.139033919 | TOMM7/DNAJA1 | 2 |
| GO:0006457 | Protein folding | 3/38 | 230/18866 | 0.011020819 | 0.185670592 | 0.154417363 | CHORDC1/DNAJA1/HSPA1B | 3 |
| GO:0097191 | Extrinsic apoptotic signaling pathway | 3/38 | 230/18866 | 0.011020819 | 0.185670592 | 0.154417363 | TNFAIP3/SERPINE1/HSPA1B | 3 |
| GO:1900034 | Regulation of cellular response to heat | 2/38 | 79/18866 | 0.011039873 | 0.185670592 | 0.154417363 | CHORDC1/HSPA1B | 2 |
| GO:0009266 | Response to temperature stimulus | 3/38 | 233/18866 | 0.011412487 | 0.189072545 | 0.157246678 | CHORDC1/DNAJA1/HSPA1B | 3 |
| GO:0001933 | Negative regulation of protein phosphorylation | 4/38 | 444/18866 | 0.011876361 | 0.193864123 | 0.161231708 | CHORDC1/TNFAIP3/IGFBP3/DNAJA1 | 4 |
| GO:0001819 | Positive regulation of cytokine production | 4/38 | 447/18866 | 0.012149539 | 0.195449108 | 0.162549898 | POLR3G/MYB/SERPINE1/HSPA1B | 4 |
| GO:1903320 | Regulation of protein modification by small protein conjugation or removal | 3/38 | 242/18866 | 0.012635607 | 0.200132614 | 0.166445047 | TNFAIP3/DNAJA1/HSPA1B | 3 |
| GO:0009896 | Positive regulation of catabolic process | 4/38 | 454/18866 | 0.01280268 | 0.200132614 | 0.166445047 | TNFAIP3/TOMM7/PIM2/HSPA1B | 4 |
| GO:0014910 | Regulation of smooth muscle cell migration | 2/38 | 86/18866 | 0.012981575 | 0.200132614 | 0.166445047 | IGFBP3/SERPINE1 | 2 |
| GO:0006469 | Negative regulation of protein kinase activity | 3/38 | 246/18866 | 0.013202523 | 0.200750689 | 0.166959084 | CHORDC1/TNFAIP3/DNAJA1 | 3 |
| GO:0008625 | Extrinsic apoptotic signaling pathway via death domain receptors | 2/38 | 89/18866 | 0.013856109 | 0.205070406 | 0.17055168 | TNFAIP3/SERPINE1 | 2 |
| GO:0043506 | Regulation of JUN kinase activity | 2/38 | 89/18866 | 0.013856109 | 0.205070406 | 0.17055168 | FZD8/DNAJA1 | 2 |
| GO:0034103 | Regulation of tissue remodeling | 2/38 | 91/18866 | 0.014453019 | 0.208348715 | 0.173278163 | TNFAIP3/S1PR1 | 2 |
| GO:0046849 | Bone remodeling | 2/38 | 91/18866 | 0.014453019 | 0.208348715 | 0.173278163 | TNFAIP3/S1PR1 | 2 |
| GO:0014909 | Smooth muscle cell migration | 2/38 | 93/18866 | 0.01506093 | 0.211615603 | 0.175995148 | IGFBP3/SERPINE1 | 2 |
| GO:0032677 | Regulation of interleukin-8 production | 2/38 | 93/18866 | 0.01506093 | 0.211615603 | 0.175995148 | SERPINE1/HSPA1B | 2 |
| GO:1904035 | Regulation of epithelial cell apoptotic process | 2/38 | 94/18866 | 0.015368982 | 0.213244626 | 0.177349964 | TNFAIP3/SERPINE1 | 2 |
| GO:0042326 | Negative regulation of phosphorylation | 4/38 | 484/18866 | 0.015856817 | 0.217297123 | 0.18072032 | CHORDC1/TNFAIP3/IGFBP3/DNAJA1 | 4 |
| GO:0033673 | Negative regulation of kinase activity | 3/38 | 268/18866 | 0.01657976 | 0.219402235 | 0.182471086 | CHORDC1/TNFAIP3/DNAJA1 | 3 |
| GO:0062207 | Regulation of pattern recognition receptor signaling pathway | 2/38 | 99/18866 | 0.016949739 | 0.219402235 | 0.182471086 | TNFAIP3/HSPA1B | 2 |
| GO:0045807 | Positive regulation of endocytosis | 2/38 | 100/18866 | 0.017273909 | 0.219402235 | 0.182471086 | APLN/SERPINE1 | 2 |
| GO:0070301 | Cellular response to hydrogen peroxide | 2/38 | 100/18866 | 0.017273909 | 0.219402235 | 0.182471086 | TNFAIP3/MYB | 2 |
| GO:0032637 | Interleukin-8 production | 2/38 | 101/18866 | 0.017600726 | 0.219402235 | 0.182471086 | SERPINE1/HSPA1B | 2 |
| GO:1990542 | Mitochondrial transmembrane transport | 2/38 | 101/18866 | 0.017600726 | 0.219402235 | 0.182471086 | SLC25A12/TOMM7 | 2 |
| GO:0035335 | Peptidyl-tyrosine dephosphorylation | 2/38 | 103/18866 | 0.018262253 | 0.219402235 | 0.182471086 | CDC25A/CDKN3 | 2 |
| GO:0048661 | Positive regulation of smooth muscle cell proliferation | 2/38 | 103/18866 | 0.018262253 | 0.219402235 | 0.182471086 | MYB/S1PR1 | 2 |
| GO:0048259 | Regulation of receptor-mediated endocytosis | 2/38 | 105/18866 | 0.018934228 | 0.219402235 | 0.182471086 | APLN/SERPINE1 | 2 |
| GO:0014812 | Muscle cell migration | 2/38 | 106/18866 | 0.019274106 | 0.219402235 | 0.182471086 | IGFBP3/SERPINE1 | 2 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 3/38 | 287/18866 | 0.019853233 | 0.219402235 | 0.182471086 | CDC25A/CDKN3/PIM2 | 3 |
| GO:0002676 | Regulation of chronic inflammatory response | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | TNFAIP3 | 1 |
| GO:0003376 | Sphingosine-1-phosphate receptor signaling pathway | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | S1PR1 | 1 |
| GO:0034135 | Regulation of toll-like receptor 2 signaling pathway | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | TNFAIP3 | 1 |
| GO:0035871 | Protein K11-linked deubiquitination | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | TNFAIP3 | 1 |
| GO:0042756 | Drinking behavior | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | APLN | 1 |
| GO:0051409 | Response to nitrosative stress | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | DNAJA1 | 1 |
| GO:0051918 | Negative regulation of fibrinolysis | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | SERPINE1 | 1 |
| GO:0098779 | Positive regulation of mitophagy in response to mitochondrial depolarization | 1/38 | 10/18866 | 0.019965185 | 0.219402235 | 0.182471086 | TOMM7 | 1 |
| GO:0031647 | Regulation of protein stability | 3/38 | 296/18866 | 0.021520184 | 0.219402235 | 0.182471086 | TOMM7/PIM2/HSPA1B | 3 |
| GO:0051348 | Negative regulation of transferase activity | 3/38 | 296/18866 | 0.021520184 | 0.219402235 | 0.182471086 | CHORDC1/TNFAIP3/DNAJA1 | 3 |
| GO:0032963 | Collagen metabolic process | 2/38 | 113/18866 | 0.021724827 | 0.219402235 | 0.182471086 | MYB/ADAMTS14 | 2 |
| GO:0070268 | Cornification | 2/38 | 113/18866 | 0.021724827 | 0.219402235 | 0.182471086 | KRT6B/KRT75 | 2 |
| GO:0016078 | tRNA catabolic process | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | POP1 | 1 |
| GO:0031652 | Positive regulation of heat generation | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | APLN | 1 |
| GO:0051574 | Positive regulation of histone H3-K9 methylation | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | MYB | 1 |
| GO:0070778 | l-aspartate transmembrane transport | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | SLC25A12 | 1 |
| GO:0090084 | Negative regulation of inclusion body assembly | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | HSPA1B | 1 |
| GO:1901526 | Positive regulation of mitophagy | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | TOMM7 | 1 |
| GO:1903265 | Positive regulation of tumor necrosis factor-mediated signaling pathway | 1/38 | 11/18866 | 0.021940223 | 0.219402235 | 0.182471086 | HSPA1B | 1 |
| GO:0031109 | Microtubule polymerization or depolymerization | 2/38 | 117/18866 | 0.023180502 | 0.220532534 | 0.183411126 | KIF18B/HSPA1B | 2 |
| GO:0045446 | Endothelial cell differentiation | 2/38 | 117/18866 | 0.023180502 | 0.220532534 | 0.183411126 | STC1/S1PR1 | 2 |
| GO:1904019 | Epithelial cell apoptotic process | 2/38 | 117/18866 | 0.023180502 | 0.220532534 | 0.183411126 | TNFAIP3/SERPINE1 | 2 |
| GO:0010755 | Regulation of plasminogen activation | 1/38 | 12/18866 | 0.023911386 | 0.220532534 | 0.183411126 | SERPINE1 | 1 |
| GO:0033629 | Negative regulation of cell adhesion mediated by integrin | 1/38 | 12/18866 | 0.023911386 | 0.220532534 | 0.183411126 | SERPINE1 | 1 |
| GO:0060536 | Cartilage morphogenesis | 1/38 | 12/18866 | 0.023911386 | 0.220532534 | 0.183411126 | STC1 | 1 |
| GO:0072537 | Fibroblast activation | 1/38 | 12/18866 | 0.023911386 | 0.220532534 | 0.183411126 | MYB | 1 |
| GO:0090520 | Sphingolipid mediated signaling pathway | 1/38 | 12/18866 | 0.023911386 | 0.220532534 | 0.183411126 | S1PR1 | 1 |
| GO:0034599 | Cellular response to oxidative stress | 3/38 | 310/18866 | 0.024262434 | 0.220532534 | 0.183411126 | TNFAIP3/MYB/HSPA1B | 3 |
| GO:0044843 | Cell cycle G1/S phase transition | 3/38 | 310/18866 | 0.024262434 | 0.220532534 | 0.183411126 | CDC25A/CDKN3/PIM2 | 3 |
| GO:0010906 | Regulation of glucose metabolic process | 2/38 | 121/18866 | 0.024675494 | 0.220532534 | 0.183411126 | IGFBP3/SLC25A12 | 2 |
| GO:0001682 | tRNA 5′-leader removal | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | POP1 | 1 |
| GO:0006596 | Polyamine biosynthetic process | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | SRM | 1 |
| GO:0031650 | Regulation of heat generation | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | APLN | 1 |
| GO:0031665 | Negative regulation of lipopolysaccharide-mediated signaling pathway | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:0034144 | Negative regulation of toll-like receptor 4 signaling pathway | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:0043568 | Positive regulation of insulin-like growth factor receptor signaling pathway | 1/38 | 13/18866 | 0.02587868 | 0.220532534 | 0.183411126 | IGFBP3 | 1 |
| GO:0032479 | Regulation of type I interferon production | 2/38 | 125/18866 | 0.026209113 | 0.220532534 | 0.183411126 | POLR3G/TNFAIP3 | 2 |
| GO:0034605 | Cellular response to heat | 2/38 | 125/18866 | 0.026209113 | 0.220532534 | 0.183411126 | CHORDC1/HSPA1B | 2 |
| GO:0006470 | Protein dephosphorylation | 3/38 | 323/18866 | 0.026971601 | 0.220532534 | 0.183411126 | IGFBP3/CDC25A/CDKN3 | 3 |
| GO:0032606 | Type I interferon production | 2/38 | 127/18866 | 0.026990194 | 0.220532534 | 0.183411126 | POLR3G/TNFAIP3 | 2 |
| GO:0002576 | Platelet degranulation | 2/38 | 129/18866 | 0.027780676 | 0.220532534 | 0.183411126 | PPBP/SERPINE1 | 2 |
| GO:0001886 | Endothelial cell morphogenesis | 1/38 | 14/18866 | 0.027842114 | 0.220532534 | 0.183411126 | STC1 | 1 |
| GO:0043650 | Dicarboxylic acid biosynthetic process | 1/38 | 14/18866 | 0.027842114 | 0.220532534 | 0.183411126 | SLC25A12 | 1 |
| GO:0051917 | Regulation of fibrinolysis | 1/38 | 14/18866 | 0.027842114 | 0.220532534 | 0.183411126 | SERPINE1 | 1 |
| GO:0090399 | Replicative senescence | 1/38 | 14/18866 | 0.027842114 | 0.220532534 | 0.183411126 | SERPINE1 | 1 |
| GO:1904925 | Positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 1/38 | 14/18866 | 0.027842114 | 0.220532534 | 0.183411126 | TOMM7 | 1 |
| GO:0010508 | Positive regulation of autophagy | 2/38 | 131/18866 | 0.028580476 | 0.220532534 | 0.183411126 | TOMM7/PIM2 | 2 |
| GO:0046887 | Positive regulation of hormone secretion | 2/38 | 131/18866 | 0.028580476 | 0.220532534 | 0.183411126 | APLN/MYB | 2 |
| GO:0002467 | Germinal center formation | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:0006089 | Lactate metabolic process | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | SLC25A12 | 1 |
| GO:0007638 | Mechanosensory behavior | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | STRBP | 1 |
| GO:0016114 | Terpenoid biosynthetic process | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | DHRS9 | 1 |
| GO:0023035 | CD40 signaling pathway | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:0034134 | Toll-like receptor 2 signaling pathway | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:0045779 | Negative regulation of bone resorption | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:1904923 | Regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TOMM7 | 1 |
| GO:2000345 | Regulation of hepatocyte proliferation | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | TNFAIP3 | 1 |
| GO:2001171 | Positive regulation of ATP biosynthetic process | 1/38 | 15/18866 | 0.029801694 | 0.220532534 | 0.183411126 | SLC25A12 | 1 |
| GO:0003158 | Endothelium development | 2/38 | 135/18866 | 0.030207696 | 0.220595672 | 0.183463636 | STC1/S1PR1 | 2 |
| GO:0015748 | Organophosphate ester transport | 2/38 | 135/18866 | 0.030207696 | 0.220595672 | 0.183463636 | SLC25A12/PITPNM2 | 2 |
| GO:0006595 | Polyamine metabolic process | 1/38 | 16/18866 | 0.031757427 | 0.224527035 | 0.186733247 | SRM | 1 |
| GO:0043508 | Negative regulation of JUN kinase activity | 1/38 | 16/18866 | 0.031757427 | 0.224527035 | 0.186733247 | DNAJA1 | 1 |
| GO:0048012 | Hepatocyte growth factor receptor signaling pathway | 1/38 | 16/18866 | 0.031757427 | 0.224527035 | 0.186733247 | ESM1 | 1 |
| GO:0090083 | Regulation of inclusion body assembly | 1/38 | 16/18866 | 0.031757427 | 0.224527035 | 0.186733247 | HSPA1B | 1 |
| GO:0099116 | tRNA 5′-end processing | 1/38 | 16/18866 | 0.031757427 | 0.224527035 | 0.186733247 | POP1 | 1 |
| GO:0072655 | Establishment of protein localization to mitochondrion | 2/38 | 140/18866 | 0.032292653 | 0.224646621 | 0.186832704 | TOMM7/DNAJA1 | 2 |
| GO:0009615 | Response to virus | 3/38 | 349/18866 | 0.032859219 | 0.224646621 | 0.186832704 | POLR3G/TNFAIP3/PIM2 | 3 |
| GO:0030336 | Negative regulation of cell migration | 3/38 | 350/18866 | 0.033098116 | 0.224646621 | 0.186832704 | IGFBP3/STC1/SERPINE1 | 3 |
| GO:0002031 | G protein-coupled receptor internalization | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | APLN | 1 |
| GO:0009084 | Glutamine family amino acid biosynthetic process | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | SLC25A12 | 1 |
| GO:0031649 | Heat generation | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | APLN | 1 |
| GO:0042448 | Progesterone metabolic process | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | DHRS9 | 1 |
| GO:0046851 | Negative regulation of bone remodeling | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | TNFAIP3 | 1 |
| GO:1901673 | Regulation of mitotic spindle assembly | 1/38 | 17/18866 | 0.033709322 | 0.224646621 | 0.186832704 | HSPA1B | 1 |
| GO:0050921 | Positive regulation of chemotaxis | 2/38 | 144/18866 | 0.03400057 | 0.224646621 | 0.186832704 | S1PR1/SERPINE1 | 2 |
| GO:0070585 | Protein localization to mitochondrion | 2/38 | 144/18866 | 0.03400057 | 0.224646621 | 0.186832704 | TOMM7/DNAJA1 | 2 |
| GO:0042542 | Response to hydrogen peroxide | 2/38 | 146/18866 | 0.034867623 | 0.229012195 | 0.190463438 | TNFAIP3/MYB | 2 |
| GO:0007043 | Cell-cell junction assembly | 2/38 | 147/18866 | 0.035304388 | 0.22932859 | 0.190726575 | CDH11/TLN2 | 2 |
| GO:0051571 | Positive regulation of histone H3-K4 methylation | 1/38 | 18/18866 | 0.035657386 | 0.22932859 | 0.190726575 | MYB | 1 |
| GO:1901524 | Regulation of mitophagy | 1/38 | 18/18866 | 0.035657386 | 0.22932859 | 0.190726575 | TOMM7 | 1 |
| GO:0010675 | Regulation of cellular carbohydrate metabolic process | 2/38 | 148/18866 | 0.035743298 | 0.22932859 | 0.190726575 | IGFBP3/SLC25A12 | 2 |
| GO:1903364 | Positive regulation of cellular protein catabolic process | 2/38 | 149/18866 | 0.036184345 | 0.22932859 | 0.190726575 | TNFAIP3/HSPA1B | 2 |
| GO:2000146 | Negative regulation of cell motility | 3/38 | 365/18866 | 0.036791555 | 0.22932859 | 0.190726575 | IGFBP3/STC1/SERPINE1 | 3 |
| GO:0061041 | Regulation of wound healing | 2/38 | 151/18866 | 0.037072807 | 0.22932859 | 0.190726575 | TNFAIP3/SERPINE1 | 2 |
| GO:0003417 | Growth plate cartilage development | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | STC1 | 1 |
| GO:0030150 | Protein import into mitochondrial matrix | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | TOMM7 | 1 |
| GO:0031643 | Positive regulation of myelination | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | SLC25A12 | 1 |
| GO:0035988 | Chondrocyte proliferation | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | STC1 | 1 |
| GO:0060252 | Positive regulation of glial cell proliferation | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | MYB | 1 |
| GO:0090026 | Positive regulation of monocyte chemotaxis | 1/38 | 19/18866 | 0.037601625 | 0.22932859 | 0.190726575 | SERPINE1 | 1 |
| GO:0002544 | Chronic inflammatory response | 1/38 | 20/18866 | 0.039542047 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0032495 | Response to muramyl dipeptide | 1/38 | 20/18866 | 0.039542047 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0034138 | Toll-like receptor 3 signaling pathway | 1/38 | 20/18866 | 0.039542047 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0071636 | Positive regulation of transforming growth factor beta production | 1/38 | 20/18866 | 0.039542047 | 0.232485102 | 0.193351763 | MYB | 1 |
| GO:2001169 | Regulation of ATP biosynthetic process | 1/38 | 20/18866 | 0.039542047 | 0.232485102 | 0.193351763 | SLC25A12 | 1 |
| GO:0006959 | Humoral immune response | 3/38 | 377/18866 | 0.039894013 | 0.232485102 | 0.193351763 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0002029 | Desensitization of G protein-coupled receptor signaling pathway | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0022401 | Negative adaptation of signaling pathway | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0034471 | ncRNA 5′-end processing | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | POP1 | 1 |
| GO:0072574 | Hepatocyte proliferation | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0072575 | Epithelial cell proliferation involved in liver morphogenesis | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0090280 | Positive regulation of calcium ion import | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | STC1 | 1 |
| GO:0098780 | Response to mitochondrial depolarisation | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | TOMM7 | 1 |
| GO:1903599 | Positive regulation of autophagy of mitochondrion | 1/38 | 21/18866 | 0.04147866 | 0.232485102 | 0.193351763 | TOMM7 | 1 |
| GO:0007398 | Ectoderm development | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | KRT6B | 1 |
| GO:0023058 | Adaptation of signaling pathway | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0034104 | Negative regulation of tissue remodeling | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0044342 | Type B pancreatic cell proliferation | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | IGFBP3 | 1 |
| GO:0045624 | Positive regulation of T-helper cell differentiation | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | MYB | 1 |
| GO:0045663 | Positive regulation of myoblast differentiation | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | IGFBP3 | 1 |
| GO:0072576 | Liver morphogenesis | 1/38 | 22/18866 | 0.04341147 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0000966 | RNA 5′-end processing | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | POP1 | 1 |
| GO:0006359 | Regulation of transcription by RNA polymerase III | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | POLR3G | 1 |
| GO:0015813 | l-glutamate transmembrane transport | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | SLC25A12 | 1 |
| GO:0031639 | Plasminogen activation | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | SERPINE1 | 1 |
| GO:0032703 | Negative regulation of interleukin-2 production | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0042026 | Protein refolding | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | HSPA1B | 1 |
| GO:0042401 | Cellular biogenic amine biosynthetic process | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | SRM | 1 |
| GO:0043576 | Regulation of respiratory gaseous exchange | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0051570 | Regulation of histone H3-K9 methylation | 1/38 | 23/18866 | 0.045340485 | 0.232485102 | 0.193351763 | MYB | 1 |
| GO:0040013 | Negative regulation of locomotion | 3/38 | 397/18866 | 0.045353407 | 0.232485102 | 0.193351763 | IGFBP3/STC1/SERPINE1 | 3 |
| GO:0034614 | Cellular response to reactive oxygen species | 2/38 | 170/18866 | 0.04592247 | 0.232485102 | 0.193351763 | TNFAIP3/MYB | 2 |
| GO:0051271 | Negative regulation of cellular component movement | 3/38 | 400/18866 | 0.046203141 | 0.232485102 | 0.193351763 | IGFBP3/STC1/SERPINE1 | 3 |
| GO:0051302 | Regulation of cell division | 2/38 | 171/18866 | 0.046408056 | 0.232485102 | 0.193351763 | PPBP/KIF18B | 2 |
| GO:0002244 | Hematopoietic progenitor cell differentiation | 2/38 | 172/18866 | 0.046895559 | 0.232485102 | 0.193351763 | MYB/KRT75 | 2 |
| GO:0009309 | Amine biosynthetic process | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | SRM | 1 |
| GO:0034143 | Regulation of toll-like receptor 4 signaling pathway | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | TNFAIP3 | 1 |
| GO:0044062 | Regulation of excretion | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | STC1 | 1 |
| GO:0051446 | Positive regulation of meiotic cell cycle | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | CDC25A | 1 |
| GO:0070841 | Inclusion body assembly | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | HSPA1B | 1 |
| GO:0090169 | Regulation of spindle assembly | 1/38 | 24/18866 | 0.047265713 | 0.232485102 | 0.193351763 | HSPA1B | 1 |
| GO:0033209 | Tumor necrosis factor-mediated signaling pathway | 2/38 | 173/18866 | 0.047384968 | 0.232485102 | 0.193351763 | TNFAIP3/HSPA1B | 2 |
| GO:0016241 | Regulation of macroautophagy | 2/38 | 176/18866 | 0.048864544 | 0.232485102 | 0.193351763 | TOMM7/PIM2 | 2 |
| GO:0000423 | Mitophagy | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | TOMM7 | 1 |
| GO:0002092 | Positive regulation of receptor internalization | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0015740 | C4-dicarboxylate transport | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | SLC25A12 | 1 |
| GO:0046697 | Decidualization | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | STC1 | 1 |
| GO:0050927 | Positive regulation of positive chemotaxis | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | S1PR1 | 1 |
| GO:0071677 | Positive regulation of mononuclear cell migration | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | SERPINE1 | 1 |
| GO:1905564 | Positive regulation of vascular endothelial cell proliferation | 1/38 | 25/18866 | 0.04918716 | 0.232485102 | 0.193351763 | APLN | 1 |
| GO:0048771 | Tissue remodeling | 2/38 | 178/18866 | 0.049860292 | 0.232485102 | 0.193351763 | TNFAIP3/S1PR1 | 2 |
Table S6.
Functional enrichment analysis (MF) of the genes associated with the upregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0001664 | G protein-coupled receptor binding | 7/40 | 293/18352 | 2.92192E-06 | 0.000514258 | 0.000387539 | CXCL3/PPBP/CXCL2/APLN/S1PR1/DNAJA1/HSPA1B | 7 |
| GO:0045236 | CXCR chemokine receptor binding | 3/40 | 18/18352 | 7.6518E-06 | 0.000673358 | 0.000507435 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0008009 | Chemokine activity | 3/40 | 49/18352 | 0.000164861 | 0.009671818 | 0.007288571 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0042379 | Chemokine receptor binding | 3/40 | 70/18352 | 0.000474548 | 0.020880096 | 0.015735001 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0005520 | Insulin-like growth factor binding | 2/40 | 29/18352 | 0.001811907 | 0.063779118 | 0.048063211 | IGFBP3/ESM1 | 2 |
| GO:0031072 | Heat shock protein binding | 3/40 | 127/18352 | 0.002652501 | 0.072483606 | 0.054622813 | CHORDC1/DNAJA1/HSPA1B | 3 |
| GO:0005178 | Integrin binding | 3/40 | 144/18352 | 0.003779843 | 0.072483606 | 0.054622813 | ESM1/TLN2/TGFBI | 3 |
| GO:0031625 | Ubiquitin protein ligase binding | 4/40 | 297/18352 | 0.003884332 | 0.072483606 | 0.054622813 | FZD8/UBE2D4/DNAJA1/HSPA1B | 4 |
| GO:0048018 | Receptor ligand activity | 5/40 | 487/18352 | 0.003943689 | 0.072483606 | 0.054622813 | CXCL3/PPBP/CXCL2/APLN/STC1 | 5 |
| GO:0030546 | Signaling receptor activator activity | 5/40 | 492/18352 | 0.004118387 | 0.072483606 | 0.054622813 | CXCL3/PPBP/CXCL2/APLN/STC1 | 5 |
| GO:0044389 | Ubiquitin-like protein ligase binding | 4/40 | 316/18352 | 0.004838462 | 0.077415397 | 0.058339354 | FZD8/UBE2D4/DNAJA1/HSPA1B | 4 |
| GO:0005125 | Cytokine activity | 3/40 | 235/18352 | 0.014454634 | 0.16029063 | 0.120793178 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0004725 | Protein tyrosine phosphatase activity | 2/40 | 101/18352 | 0.020420482 | 0.16029063 | 0.120793178 | CDC25A/CDKN3 | 2 |
| GO:0005126 | Cytokine receptor binding | 3/40 | 271/18352 | 0.021045942 | 0.16029063 | 0.120793178 | CXCL3/PPBP/CXCL2 | 3 |
| GO:0005200 | Structural constituent of cytoskeleton | 2/40 | 104/18352 | 0.02156948 | 0.16029063 | 0.120793178 | KRT6B/TLN2 | 2 |
| GO:0051087 | Chaperone binding | 2/40 | 104/18352 | 0.02156948 | 0.16029063 | 0.120793178 | CDC25A/DNAJA1 | 2 |
| GO:0018455 | Alcohol dehydrogenase [NAD(P)+] activity | 1/40 | 10/18352 | 0.02158869 | 0.16029063 | 0.120793178 | DHRS9 | 1 |
| GO:0030957 | Tat protein binding | 1/40 | 10/18352 | 0.02158869 | 0.16029063 | 0.120793178 | DNAJA1 | 1 |
| GO:0033204 | Ribonuclease P RNA binding | 1/40 | 10/18352 | 0.02158869 | 0.16029063 | 0.120793178 | POP1 | 1 |
| GO:0004222 | Metalloendopeptidase activity | 2/40 | 108/18352 | 0.023142512 | 0.16029063 | 0.120793178 | ADAMTS6/ADAMTS14 | 2 |
| GO:0008525 | Phosphatidylcholine transporter activity | 1/40 | 11/18352 | 0.023722397 | 0.16029063 | 0.120793178 | PITPNM2 | 1 |
| GO:0004526 | Ribonuclease P activity | 1/40 | 12/18352 | 0.025851567 | 0.16029063 | 0.120793178 | POP1 | 1 |
| GO:0061578 | Lys63-specific deubiquitinase activity | 1/40 | 12/18352 | 0.025851567 | 0.16029063 | 0.120793178 | TNFAIP3 | 1 |
| GO:0051082 | Unfolded protein binding | 2/40 | 118/18352 | 0.027274787 | 0.16029063 | 0.120793178 | DNAJA1/HSPA1B | 2 |
| GO:0031994 | Insulin-like growth factor I binding | 1/40 | 13/18352 | 0.027976209 | 0.16029063 | 0.120793178 | IGFBP3 | 1 |
| GO:0072542 | Protein phosphatase activator activity | 1/40 | 13/18352 | 0.027976209 | 0.16029063 | 0.120793178 | IGFBP3 | 1 |
| GO:0005179 | Hormone activity | 2/40 | 122/18352 | 0.029005294 | 0.16029063 | 0.120793178 | APLN/STC1 | 2 |
| GO:0005313 | l-glutamate transmembrane transporter activity | 1/40 | 14/18352 | 0.030096333 | 0.16029063 | 0.120793178 | SLC25A12 | 1 |
| GO:0004549 | tRNA-specific ribonuclease activity | 1/40 | 15/18352 | 0.032211948 | 0.16029063 | 0.120793178 | POP1 | 1 |
| GO:0042813 | Wnt-activated receptor activity | 1/40 | 15/18352 | 0.032211948 | 0.16029063 | 0.120793178 | FZD8 | 1 |
| GO:0005229 | Intracellular calcium activated chloride channel activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | TTYH2 | 1 |
| GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | KIF18B | 1 |
| GO:0015172 | Acidic amino acid transmembrane transporter activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | SLC25A12 | 1 |
| GO:0015556 | C4-dicarboxylate transmembrane transporter activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | SLC25A12 | 1 |
| GO:0019211 | Phosphatase activator activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | IGFBP3 | 1 |
| GO:0045125 | Bioactive lipid receptor activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | S1PR1 | 1 |
| GO:0061778 | Intracellular chloride channel activity | 1/40 | 16/18352 | 0.034323063 | 0.16029063 | 0.120793178 | TTYH2 | 1 |
| GO:0019838 | Growth factor binding | 2/40 | 136/18352 | 0.035395696 | 0.16029063 | 0.120793178 | IGFBP3/ESM1 | 2 |
| GO:0002020 | Protease binding | 2/40 | 137/18352 | 0.035871398 | 0.16029063 | 0.120793178 | TNFAIP3/SERPINE1 | 2 |
| GO:0016854 | Racemase and epimerase activity | 1/40 | 17/18352 | 0.036429689 | 0.16029063 | 0.120793178 | DHRS9 | 1 |
| GO:0004745 | Retinol dehydrogenase activity | 1/40 | 20/18352 | 0.042722715 | 0.164575436 | 0.124022159 | DHRS9 | 1 |
| GO:0008320 | Protein transmembrane transporter activity | 1/40 | 20/18352 | 0.042722715 | 0.164575436 | 0.124022159 | TOMM7 | 1 |
| GO:0140318 | Protein transporter activity | 1/40 | 20/18352 | 0.042722715 | 0.164575436 | 0.124022159 | TOMM7 | 1 |
| GO:0005355 | Glucose transmembrane transporter activity | 1/40 | 21/18352 | 0.044811472 | 0.164575436 | 0.124022159 | PPBP | 1 |
| GO:0015149 | Hexose transmembrane transporter activity | 1/40 | 21/18352 | 0.044811472 | 0.164575436 | 0.124022159 | PPBP | 1 |
| GO:0050750 | Low-density lipoprotein particle receptor binding | 1/40 | 21/18352 | 0.044811472 | 0.164575436 | 0.124022159 | DNAJA1 | 1 |
| GO:0070530 | K63-linked polyubiquitin modification-dependent protein binding | 1/40 | 21/18352 | 0.044811472 | 0.164575436 | 0.124022159 | TNFAIP3 | 1 |
| GO:0022884 | Macromolecule transmembrane transporter activity | 1/40 | 22/18352 | 0.046895785 | 0.164575436 | 0.124022159 | TOMM7 | 1 |
| GO:0120014 | Phospholipid transfer activity | 1/40 | 22/18352 | 0.046895785 | 0.164575436 | 0.124022159 | PITPNM2 | 1 |
| GO:0015145 | Monosaccharide transmembrane transporter activity | 1/40 | 23/18352 | 0.048975663 | 0.164575436 | 0.124022159 | PPBP | 1 |
Table S7.
Functional enrichment analysis (CC) of the DEGs associated with the upregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| GO:0031093 | Platelet alpha granule lumen | 2/39 | 67/19559 | 0.007893629 | 0.247850692 | 0.220518786 | PPBP/SERPINE1 | 2 |
| GO:0031091 | Platelet alpha granule | 2/39 | 91/19559 | 0.01418764 | 0.247850692 | 0.220518786 | PPBP/SERPINE1 | 2 |
| GO:0045095 | Keratin filament | 2/39 | 95/19559 | 0.015392516 | 0.247850692 | 0.220518786 | KRT6B/KRT75 | 2 |
| GO:0030681 | Multimeric ribonuclease P complex | 1/39 | 10/19559 | 0.019766209 | 0.247850692 | 0.220518786 | POP1 | 1 |
| GO:0000235 | Astral microtubule | 1/39 | 11/19559 | 0.021721763 | 0.247850692 | 0.220518786 | KIF18B | 1 |
| GO:0002177 | Manchette | 1/39 | 11/19559 | 0.021721763 | 0.247850692 | 0.220518786 | STRBP | 1 |
| GO:0005818 | Aster | 1/39 | 11/19559 | 0.021721763 | 0.247850692 | 0.220518786 | KIF18B | 1 |
| GO:0030677 | Ribonuclease P complex | 1/39 | 14/19559 | 0.027565644 | 0.247850692 | 0.220518786 | POP1 | 1 |
| GO:1990023 | Mitotic spindle midzone | 1/39 | 14/19559 | 0.027565644 | 0.247850692 | 0.220518786 | KIF18B | 1 |
| GO:0098554 | Cytoplasmic side of endoplasmic reticulum membrane | 1/39 | 15/19559 | 0.029506035 | 0.247850692 | 0.220518786 | DNAJA1 | 1 |
| GO:0005666 | RNA polymerase III complex | 1/39 | 18/19559 | 0.035304599 | 0.269598759 | 0.23986857 | POLR3G | 1 |
| GO:0035371 | Microtubule plus-end | 1/39 | 23/19559 | 0.044893941 | 0.285010639 | 0.253580895 | KIF18B | 1 |
| GO:0098799 | Outer mitochondrial membrane protein complex | 1/39 | 24/19559 | 0.046800633 | 0.285010639 | 0.253580895 | TOMM7 | 1 |
Table S8.
Functional enrichment analysis (KEGG) of genes associated with the upregulated genes
| ID | Description | GeneRatio | BgRatio | p-value | p.adjust | q-value | geneID | Count |
|---|---|---|---|---|---|---|---|---|
| hsa05134 | Legionellosis | 3/21 | 57/8223 | 0.000384425 | 0.027678575 | 0.022256164 | CXCL3/CXCL2/HSPA1B | 3 |
| hsa04657 | IL-17 signaling pathway | 3/21 | 94/8223 | 0.001657299 | 0.039867397 | 0.032057118 | CXCL3/TNFAIP3/CXCL2 | 3 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3/21 | 100/8223 | 0.001979642 | 0.039867397 | 0.032057118 | CXCL3/PPBP/CXCL2 | 3 |
| hsa04064 | NF-kappa B signaling pathway | 3/21 | 104/8223 | 0.002214855 | 0.039867397 | 0.032057118 | CXCL3/TNFAIP3/CXCL2 | 3 |
| hsa04668 | TNF signaling pathway | 3/21 | 114/8223 | 0.002877066 | 0.041429752 | 0.033313397 | CXCL3/TNFAIP3/CXCL2 | 3 |
| hsa04218 | Cellular senescence | 3/21 | 156/8223 | 0.006931269 | 0.083175226 | 0.066880664 | IGFBP3/CDC25A/SERPINE1 | 3 |
| hsa04141 | Protein processing in endoplasmic reticulum | 3/21 | 171/8223 | 0.008922601 | 0.091775328 | 0.073795951 | UBE2D4/DNAJA1/HSPA1B | 3 |
| hsa04621 | NOD-like receptor signaling pathway | 3/21 | 186/8223 | 0.011219936 | 0.095815294 | 0.077044462 | CXCL3/TNFAIP3/CXCL2 | 3 |
| hsa04062 | Chemokine signaling pathway | 3/21 | 192/8223 | 0.012226679 | 0.095815294 | 0.077044462 | CXCL3/PPBP/CXCL2 | 3 |
| hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2/21 | 70/8223 | 0.013513912 | 0.095815294 | 0.077044462 | CXCL3/CXCL2 | 2 |
| hsa04115 | p53 signaling pathway | 2/21 | 73/8223 | 0.014638448 | 0.095815294 | 0.077044462 | IGFBP3/SERPINE1 | 2 |
| hsa05417 | Lipid and atherosclerosis | 3/21 | 215/8223 | 0.016561503 | 0.099369018 | 0.079901988 | CXCL3/CXCL2/HSPA1B | 3 |
| hsa05323 | Rheumatoid arthritis | 2/21 | 93/8223 | 0.023111727 | 0.128003412 | 0.102926721 | CXCL3/CXCL2 | 2 |
| hsa05146 | Amoebiasis | 2/21 | 102/8223 | 0.027448456 | 0.141163486 | 0.113508651 | CXCL3/CXCL2 | 2 |
| hsa04060 | Cytokine-cytokine receptor interaction | 3/21 | 295/8223 | 0.037680574 | 0.180866757 | 0.145433796 | CXCL3/PPBP/CXCL2 | 3 |
| hsa04371 | Apelin signaling pathway | 2/21 | 139/8223 | 0.048309475 | 0.200783275 | 0.16144854 | APLN/SERPINE1 | 2 |
| hsa05162 | Measles | 2/21 | 139/8223 | 0.048309475 | 0.200783275 | 0.16144854 | TNFAIP3/HSPA1B | 2 |